CN104974745A - Amphiphilic luminescent substance with aggregation-induced luminescent properties and its application - Google Patents
Amphiphilic luminescent substance with aggregation-induced luminescent properties and its application Download PDFInfo
- Publication number
- CN104974745A CN104974745A CN201510159050.9A CN201510159050A CN104974745A CN 104974745 A CN104974745 A CN 104974745A CN 201510159050 A CN201510159050 A CN 201510159050A CN 104974745 A CN104974745 A CN 104974745A
- Authority
- CN
- China
- Prior art keywords
- aggregation
- luminescent substance
- tpe
- amphiphilic
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/48—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/14—Macromolecular compounds
- C09K2211/1441—Heterocyclic
- C09K2211/1466—Heterocyclic containing nitrogen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/182—Metal complexes of the rare earth metals, i.e. Sc, Y or lanthanide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Materials Engineering (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及荧光材料技术领域,具体涉及一种两亲性的具有聚集诱导发光特性的发光物及其应用。The invention relates to the technical field of fluorescent materials, in particular to an amphiphilic luminescent substance with aggregation-induced luminescent properties and an application thereof.
背景技术Background technique
近年来,已经发现一系列螺旋状分子在溶液中不发光,但通过聚合形成后会被诱导发出强光,这种聚集诱导发光(aggregation-induced eimission,AIE)的现象与传统荧光素表现出的聚集荧光淬灭效应是完全相反的。利用这个新效应,AIE发光材料可以在许多高科技领域进行应用,如化学传感器、生物探头、免疫标记、刺激反应材料和固态发射器等[Chem.Commun.2001,18,1740;J.Mater.Chem.,2001,11,2974;Chem.Soc.Rev.,2011,40,5361;Adv.Funct.Mater.,2012,22,771;Chem.Commun.,2011,47,7323;Adv.HealthcareMater.,2013,2,500;Acc.Chem.Res.,2013,46,2441;Chem.Commun.2013,49,11335;Biomaterials 2008,29,1345;US 8,029,767;US 2013/0029325;CN103175768]。四苯乙烯(tetraphenylethene,TPE)和六苯基硅杂环戊二烯(hexaphenylsiole,HPS)是原型AIE分子,其具有易合成、固态情况下的高量子产率以及高化学稳定性和光稳定性等优势,但是其疏水性质极大地限制了在生物领域的应用,为了降低其疏水性或提高其亲水性,在其结构中引入了带电的功能基团。例如,带有两个或四个铵基的TPE在水性溶液中发光较弱,但加入带阴电荷的生物分子就变成强发光体,如加入小牛胸腺DNA和牛血清白蛋白(BSA)[Chem.Commun.,2006,3705;Chem.–Eur.J.,2008,14,6428.]。该阴离子TPE衍生物将磺酸基团带入进BSA的主体折叠结构的疏水腔内,由于分子内旋转的限制(restriction of intramolecularrotation,RIR)使得发光增强。当通过引入表面活性剂(如十二烷基硫酸钠SDS)使得BSA不折叠时,则不再发光[J.Phys.Chem.B,2007,111,11817]。Tang和他的共同工作者们报道了包含有TPE配基的聚N-异丙基丙烯酰胺(PNIPAM)的聚合物[Chem.Commun.,2009,4974],通过荧光技术,TPE标记的PNIPAM链可以用于跟踪温度引起的聚合物的构象变化。另一方面,很少有研究和报道两亲性的AIE分子。在结构上,两亲性分子为表面活性剂以及通常既含有疏水结构单元又含有亲水结构单元的有机化合物。大部分两亲性分子的疏水尾为支链、直链或芳族烃链,同时亲水头不带电荷、负电荷和正电荷,有时分别被称为非离子表面活性剂、阴离子表面活性剂和阳离子表面活性剂。因此,两亲性分子由水不溶性配基和水溶性配基构成。在水性溶液中,两亲性分子形成聚合物,如胶体和胶团等,其中疏水尾聚集形成核心,亲水头集中于表面并与周围的水环境相接触。聚合物的形状和大小主要取决于两亲性分子的结构以及分子的亲水性和疏水性的平衡关系。两亲性分子广泛存在于我们的日常生活物品,包括清洁剂、织物柔软剂、乳剂、绘画颜料、墨水和化妆品等,以及存在于生物利用方面,如蛋白提取、细胞质膜、给药等等。两亲性和AIE特性的结合可以产生一系列新的荧光分子用于化学和生物应用方面。In recent years, it has been found that a series of helical molecules do not emit light in solution, but are induced to emit strong light after being formed by aggregation. The aggregation fluorescence quenching effect is exactly the opposite. Using this new effect, AIE luminescent materials can be applied in many high-tech fields, such as chemical sensors, biological probes, immunolabeling, stimuli-responsive materials and solid-state emitters, etc. [Chem.Commun.2001,18,1740; J.Mater. Chem., 2001, 11, 2974; Chem. Soc. Rev., 2011, 40, 5361; Adv. Funct. Mater., 2012, 22, 771; Chem. Commun., 2011, 47, 7323; , 2,500; Acc.Chem.Res., 2013,46,2441; Chem.Commun.2013,49,11335; Biomaterials 2008,29,1345; US 8,029,767; US 2013/0029325; CN103175768]. Tetraphenylethylene (tetraphenylethene, TPE) and hexaphenylsilacyclopentadiene (hexaphenylsiole, HPS) are prototype AIE molecules, which have easy synthesis, high quantum yield in solid state, high chemical stability and photostability, etc. Advantages, but its hydrophobic nature greatly limits its application in the biological field. In order to reduce its hydrophobicity or improve its hydrophilicity, charged functional groups are introduced into its structure. For example, TPE with two or four ammonium groups emits weakly in aqueous solution, but becomes a strong emitter when added with negatively charged biomolecules, such as calf thymus DNA and bovine serum albumin (BSA)[ Chem. Commun., 2006, 3705; Chem.–Eur. J., 2008, 14, 6428.]. The anionic TPE derivative brings the sulfonic acid group into the hydrophobic cavity of the main folding structure of BSA, and the luminescence is enhanced due to the restriction of intramolecular rotation (RIR). When BSA is unfolded by introducing a surfactant (such as sodium dodecyl sulfate SDS), it no longer emits light [J. Phys. Chem. B, 2007, 111, 11817]. Tang and his co-workers reported poly-N-isopropylacrylamide (PNIPAM) polymers containing TPE ligands [Chem. Can be used to track temperature-induced conformational changes in polymers. On the other hand, there are few studies and reports on amphiphilic AIE molecules. Structurally, amphiphilic molecules are surfactants and organic compounds that generally contain both hydrophobic and hydrophilic structural units. The hydrophobic tails of most amphiphilic molecules are branched, linear or aromatic hydrocarbon chains, while the hydrophilic heads are uncharged, negatively charged and positively charged, sometimes referred to as nonionic surfactants, anionic surfactants and cationic surfactant. Thus, an amphiphilic molecule is composed of a water-insoluble ligand and a water-soluble ligand. In aqueous solution, amphiphilic molecules form polymers, such as colloids and micelles, in which the hydrophobic tails gather to form a core, and the hydrophilic heads are concentrated on the surface and in contact with the surrounding aqueous environment. The shape and size of polymers mainly depend on the structure of amphiphilic molecules and the balance between hydrophilicity and hydrophobicity of molecules. Amphiphilic molecules are widely found in our daily life items, including detergents, fabric softeners, emulsions, paints, inks and cosmetics, as well as in biological utilization, such as protein extraction, cell plasma membrane, drug delivery and so on. The combination of amphiphilic and AIE properties can generate a series of new fluorescent molecules for chemical and biological applications.
发明内容Contents of the invention
本发明的目的是提供一种两亲性的具有聚集诱导发光特性的发光物及其应用,解决现有技术中的具有聚集诱导发光特性的发光物为疏水性的发光物而导致应用受限的问题。The purpose of the present invention is to provide an amphiphilic luminescent substance with aggregation-induced luminescent properties and its application, which solves the problem that the luminescent substance with aggregation-induced luminescent characteristics in the prior art is hydrophobic, which leads to limited applications. question.
本发明解决技术问题所采用的技术方案是:一种两亲性的具有聚集诱导发光特性的发光物,包含具有聚集诱导/增强发光特性的疏水性单元,在具有聚集诱导/增强发光特性的疏水单元上连接有亲水性单元,所述发光物的结构式选自以下I、II、III、IV、V和VI中的任一种;The technical solution adopted by the present invention to solve the technical problem is: an amphiphilic luminescent substance with aggregation-induced luminescent properties, comprising a hydrophobic unit with aggregation-induced/enhanced luminescent properties, and a hydrophobic A hydrophilic unit is attached to the unit, and the structural formula of the luminescent substance is selected from any of the following I, II, III, IV, V and VI;
其中,表示具有聚集诱导/增强发光特性的疏水性单元;in, Represents a hydrophobic unit with aggregation-inducing/enhanced luminescence properties;
表示亲水性单元; represents a hydrophilic unit;
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述发光物可溶于水,且所述发光物形成的水溶液的浓度≥临界胶束浓度时可形成胶束。In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the luminescent substance is soluble in water, and micelles can be formed when the concentration of the aqueous solution formed by the luminescent substance is greater than or equal to the critical micelle concentration.
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述具有聚集诱导/增强发光特性的疏水性单元包括至少一第一主体结构,所述主体结构选自包含有下述任一结构的基团:In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the hydrophobic unit with aggregation-induced/enhanced luminescent properties includes at least one first host structure, and the host structure is selected from any of the following: A group of structures:
其中,R和R(X)分别表示与所述具有聚集诱导/增强发光特性的疏水性单元相连接的亲水性单元。Wherein, R and R(X) respectively represent a hydrophilic unit connected to the hydrophobic unit with aggregation-inducing/enhancing luminescence properties.
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述亲水性单元分别选自含有OH、铵盐、氨基、硫醇、乙基乙二醇、磺酸盐、磷酸盐和羧酸盐中至少一种的基团。In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the hydrophilic units are selected from the group consisting of OH, ammonium salt, amino group, mercaptan, ethyl glycol, sulfonate, phosphate and at least one of carboxylate groups.
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述具有聚集诱导/增强发光特性的疏水性单元包含有结构为的基团,所述亲水性单元包含有乙基乙二醇基团;具体地,所述发光物包含有下述结构式P1/6、P2/6和P3/6中任一结构式的基团:其中n、m、o和p分别表示2~3000的自然数,In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the hydrophobic unit with aggregation-induced/enhanced luminescent properties contains a structure of The group, the hydrophilic unit contains an ethyl ethylene glycol group; specifically, the luminescent substance contains a group of any one of the following structural formulas P1/6, P2/6 and P3/6 : where n, m, o and p represent natural numbers from 2 to 3000 respectively,
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述发光物在追踪细胞中的应用、在制备细胞追踪器中的应用、在制备用于追踪细胞的探针中的应用或在监测细胞内药物释放过程中的应用。In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the application of the luminescent substance in tracking cells, in the preparation of cell trackers, and in the preparation of probes for tracking cells Or in monitoring the application of intracellular drug release process.
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述亲水性单元包含至少一第二主体结构,所述第二主体结构选自包含有下述任一结构的基团:In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the hydrophilic unit includes at least one second host structure, and the second host structure is selected from groups including any of the following structures :
和 and
其中R1、R2、R3、R4和R5分别选自包含有H、烷基、不饱合烷基、异烷基、环烷基、异环烷基、芳烃基、异芳烃基、以及CnH2n+1、C10H7、C12H9、OC6H5、OC10H7、OC12H9、CnH2nCOOH、CnH2nNCS、CnH2nN3、CnH2nNH2、CnH2nSH、CnH2nCl、CnH2nBr、CnH2nI中的至少一种的基团,n为自然数;Wherein R 1 , R 2 , R 3 , R 4 and R 5 are respectively selected from the group consisting of H, alkyl, unsaturated alkyl, isoalkyl, cycloalkyl, heterocycloalkyl, aromatic hydrocarbon group, heteroaryl hydrocarbon group , and C n H 2n+1 , C 10 H 7 , C 12 H 9 , OC 6 H 5 , OC 10 H 7 , OC 12 H 9 , C n H 2n COOH, C n H 2n NCS, C n H 2n A group of at least one of N 3 , C n H 2n NH 2 , C n H 2n SH, C n H 2n Cl, C n H 2n Br, and C n H 2n I, n is a natural number;
X-为反荷离子,X-选自于I-、Cl-、Br-、PF6 -、ClO4 -、BF4 -、BPh4 -、CH3PhSO3 -。X - is a counter ion, and X - is selected from I - , Cl - , Br - , PF 6 - , ClO 4 - , BF 4 - , BPh 4 - , CH 3 PhSO 3 - .
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述具有聚集诱导/增强发光特性的疏水性单元包含有结构为的基团,所述亲水性单元包含有结构为的基团,其中R1为丙烷基,X-为Br-;具体地,所述发光物包含有下述结构式TPE-MEM的基团:In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the hydrophobic unit with aggregation-induced/enhanced luminescent properties contains a structure of The group, the hydrophilic unit contains a structure of group, wherein R 1 is a propane group, X - is Br - ; specifically, the luminescent substance contains a group with the following structural formula TPE-MEM:
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述发光物在特异性选择细胞膜染色中的应用、在制备特异性选择细胞膜染色剂中的应用、在制备特异性选择细胞膜染色的探针中的应用、在制备光敏剂中的应用以及在制备光线疗法药物中的应用或在制备用于治疗癌症的光线疗法药物中的应用。In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the application of the luminescent substance in the staining of specific selection cell membrane, the application of the preparation of specific selection cell membrane staining agent, the preparation of specific selection cell membrane Use in dyed probes, use in the preparation of photosensitizers and use in the preparation of phototherapy medicaments or in the preparation of phototherapy medicaments for the treatment of cancer.
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述发光物可以与金属离子复合,所述金属离子选自La3+、Pr3+、Nd3+、Pm3+、Sm3+、Eu3+、Gd3+、Tb3+、Ce3+、Dy3+、Ho3+、Er3+、Tm3+、Yb3+和Lu3+中的至少一种。In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the luminescent substance can be complexed with metal ions selected from La 3+ , Pr 3+ , Nd 3+ , Pm 3+ , At least one of Sm 3+ , Eu 3+ , Gd 3+ , Tb 3+ , Ce 3+ , Dy 3+ , Ho 3+ , Er 3+ , Tm 3+ , Yb 3+ and Lu 3+ .
在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述金属离子为Gd3+,所述具有聚集诱导/增强发光特性的疏水性单元包含有结构为的基团,所述亲水性单元包含有乙基乙二醇基团;具体地,所述发光物包含有下述结构式TPE-2Gd的基团:In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the metal ion is Gd 3+ , and the hydrophobic unit with aggregation-induced/enhanced luminescent properties contains a structure of The group, the hydrophilic unit contains an ethyl glycol group; specifically, the luminescent substance contains a group of the following structural formula TPE-2Gd:
在本发明的两亲性的具有聚集诱导发光特性的发光物中,在本发明的两亲性的具有聚集诱导发光特性的发光物中,所述发光物在特异性选择细胞质区染色中的应用,在制备特异性选择细胞质区染色的染色剂中的应用、在细胞成像中的应用、在追踪肿瘤细胞中的应用、在制备追踪肿瘤细胞的肿瘤细胞追踪器中的应用或在制备核磁共振成像造影剂中的应用。In the amphiphilic luminescent substance with aggregation-induced luminescent properties of the present invention, the application of the luminescent substance in the specific selection of cytoplasmic region staining , for use in the preparation of stains for the specific selection of staining in cytoplasmic regions, in cell imaging, in tracking tumor cells, in the preparation of tumor cell trackers for tracking tumor cells, or in the preparation of nuclear magnetic resonance imaging Application of contrast agents.
本发明还详细说明了上述两亲性的具有聚集诱导发光特性的发光物在追踪细胞中的应用、在制备细胞追踪器中的应用、在制备用于追踪细胞的探针中的应用、在监测细胞内药物释放过程中的应用、在特异性选择细胞膜染色中的应用、在制备特异性选择细胞膜染色剂中的应用、在制备特异性选择细胞膜染色的探针中的应用、在制备光敏剂中的应用、在制备光线疗法药物中的应用或在制备用于治疗癌症的光线疗法药物中的应用、在特异性选择细胞质区染色中的应用,在制备特异性选择细胞质区染色的染色剂中的应用、在细胞成像中的应用、在追踪肿瘤细胞中的应用、在制备追踪肿瘤细胞的肿瘤细胞追踪器中的应用或在制备核磁共振成像造影剂中的应用。The present invention also specifies the application of the above-mentioned amphiphilic luminescent substances with aggregation-induced luminescent properties in tracking cells, the application in preparing cell trackers, the application in preparing probes for tracking cells, and the application in monitoring cells. Application in the process of intracellular drug release, application in specific selection of cell membrane staining, application in preparation of specific selection cell membrane staining, application in preparation of probes for specific selection of cell membrane staining, application in preparation of photosensitizers application in the preparation of phototherapy drugs or in the preparation of phototherapy drugs for the treatment of cancer, the application in the staining of specific selective cytoplasmic regions, the use in the preparation of staining agents for specific selective cytoplasmic region staining applications, applications in cell imaging, applications in tracking tumor cells, applications in the preparation of tumor cell trackers for tracking tumor cells, or applications in the preparation of MRI contrast agents.
实施本发明的两亲性的具有聚集诱导发光特性的发光物及其应用,具有以下有益效果:本发明的发光物通过在典型的聚集诱导发光特性(AIE)的疏水性单元上连接亲水性单元制备而成,该发光物可用于荧光化学传感器以及用于制备为活细胞和动物成像荧光染色的荧光染色剂,这些两亲性的染色剂特别适合用于生物聚合物的荧光标记,可以作为AIE激活的生物相容性探针,使得其在临床癌症成像、诊断以及治疗方面均可应用。具体地,(1)本发明制备了非离子的水溶性聚乙二醇(PEG)修饰的四苯乙烯(TPEs)发光物,通过叠氮化炔烃环加成反应制备而成,对其聚集诱导发光、胶束化、热敏特性以及可用于作为细胞内成像的荧光可视剂均进行了研究;(2)本发明还制备了阳离子的四苯乙烯基的吡啶盐发光物,其具有AIE特性,可选择性对细胞膜染色,该发光物在房间灯光照射下还可以产生活性氧(ROS),这使得在温和的条件下就可以观察到细胞坏死和光疗的效果;(3)本发明还成功合成了新型的双模式核磁共振成像(MRI)造影剂(TPE-2Gd),包含有疏水性四苯乙烯单元和亲水性的二乙烯三胺五乙酸-钆复合物,具有磁性且可以荧光成像,实验结果显示其是一种理想的MRI造影剂,具有用于诊断的长循环寿命以及用于机体清除的足够短的短循环寿命。The implementation of the amphiphilic luminescent substance with aggregation-induced luminescent properties and its application of the present invention has the following beneficial effects: the luminescent substance of the present invention is connected with a hydrophilic unit on a typical aggregation-induced luminescent characteristic (AIE) hydrophobic unit. The luminescent substance can be used for fluorescent chemical sensors and fluorescent dyes for imaging fluorescent dyes in living cells and animals. These amphiphilic dyes are especially suitable for fluorescent labeling of biopolymers and can be used as The biocompatible probe activated by AIE makes it applicable in clinical cancer imaging, diagnosis and therapy. Specifically, (1) the present invention prepares non-ionic water-soluble polyethylene glycol (PEG) modified tetraphenylethylene (TPEs) luminescent material, which is prepared by azide alkyne cycloaddition reaction, and its aggregation Induced luminescence, micellization, thermosensitivity, and the fluorescent visualization agent that can be used as intracellular imaging have all been studied; (2) the present invention also prepared a cationic tetrastyryl pyridinium salt luminescent substance, which has an AIE characteristics, can selectively dye the cell membrane, and the luminescent substance can also generate reactive oxygen species (ROS) under room light irradiation, which makes it possible to observe the effects of cell necrosis and phototherapy under mild conditions; (3) the present invention also Successfully synthesized a novel dual-mode magnetic resonance imaging (MRI) contrast agent (TPE-2Gd), which contains hydrophobic tetraphenylethylene units and hydrophilic diethylenetriaminepentaacetic acid-gadolinium complexes, is magnetic and can fluoresce Imaging, experimental results show that it is an ideal MRI contrast agent with a long cycle life for diagnosis and a short cycle life short enough for body clearance.
附图说明Description of drawings
图1为本发明实施例1中P1/6、P2/6和P3/6发光物的合成路线图;Figure 1 is a synthetic route diagram of P1/6, P2/6 and P3/6 luminescent substances in Example 1 of the present invention;
图2为本发明实施例2中TPE-MEM发光物的合成路线图;Fig. 2 is a synthetic route diagram of TPE-MEM luminescent substance in Example 2 of the present invention;
图3为本发明实施例3中TPE-2Gd发光物的合成路线图;Figure 3 is a synthetic route diagram of TPE-2Gd luminescent material in Example 3 of the present invention;
图4A为P1/6发光物(0.25mg/mL)在不同含水量的THF/H2O混合液中由365nm波长的紫外光照射的照片;4A is a photo of P1/6 luminescent substance (0.25mg/mL) irradiated by ultraviolet light with a wavelength of 365nm in THF/H 2 O mixtures with different water contents;
图4B为P1/6发光物(0.25mg/mL)在不同己烷含量的THF/己烷混合液中由365nm波长的紫外光照射的照片;Figure 4B is a photo of P1/6 luminescent material (0.25mg/mL) irradiated by ultraviolet light with a wavelength of 365nm in THF/hexane mixtures with different hexane contents;
图4C为P1/6、P2/6和P3/6发光物分别在不同组成的THF/H2O混合液中的相对强度与不同组成的THF/H2O混合液中含水量之间的相关曲线图;其中,发光物浓度为0.25mg/mL,激发波长(nm):320(P1/6)、335(P2/6)以及350(P3/6);Figure 4C shows the correlation between the relative intensities of P1/6, P2/6 and P3/6 luminescent substances in THF/H 2 O mixtures of different compositions and the water content in THF/H 2 O mixtures of different compositions Graph; wherein, the concentration of the luminescent substance is 0.25 mg/mL, the excitation wavelength (nm): 320 (P1/6), 335 (P2/6) and 350 (P3/6);
图4D为P1/6、P2/6和P3/6发光物分别在不同组成的THF/己烷混合液中的相对强度与不同组成的THF/己烷混合液中己烷含量之间的相关曲线图;其中,发光物浓度为0.25mg/mL,激发波长(nm):320(P1/6)、335(P2/6)以及350(P3/6);Figure 4D is the correlation curve between the relative intensities of P1/6, P2/6 and P3/6 luminescent substances in THF/hexane mixtures of different compositions and the hexane content in THF/hexane mixtures of different compositions Figure; wherein, the concentration of the luminescent substance is 0.25 mg/mL, the excitation wavelength (nm): 320 (P1/6), 335 (P2/6) and 350 (P3/6);
图5A为不同浓度的P1/6发光物的水溶液(0.002-2mg/mL)由365nm波长的紫外光照射的照片;Fig. 5A is a photo of aqueous solutions (0.002-2mg/mL) of P1/6 luminescent substances with different concentrations irradiated by ultraviolet light with a wavelength of 365nm;
图5B为不同浓度的P1/6发光物的水溶液的PL光谱图;Figure 5B is a PL spectrum diagram of aqueous solutions of P1/6 luminescent substances with different concentrations;
图5C为P1/6、P2/6和P3/6发光物的I/I0值与对应在水中的浓度之间的相关曲线图;Figure 5C is a correlation graph between the I/I 0 values of P1/6, P2/6 and P3/6 luminescent substances and the corresponding concentrations in water;
图6为利用CCK8实验分析P1/6发光物对HepG2细胞的24小时的细胞毒性的相关图;Figure 6 is a correlation diagram of analyzing the 24-hour cytotoxicity of P1/6 luminescent substance to HepG2 cells by CCK8 experiment;
图7为不同浓度的P1/6发光物对活的HepG2细胞染色12小时的成像图;Figure 7 is an imaging diagram of different concentrations of P1/6 luminescent substances staining live HepG2 cells for 12 hours;
图8为200μg/mL浓度的P2/6和P3/6发光物对活的HepG2细胞染色24小时的成像图;Figure 8 is an imaging image of 200 μg/mL concentrations of P2/6 and P3/6 luminescent substances staining live HepG2 cells for 24 hours;
图9为长期追踪由150μg/mL的P1/6发光物染色24小时后的第一代至第五代的HepG2细胞的成像图;Figure 9 is a long-term tracking image of HepG2 cells from the first to fifth passages stained with 150 μg/mL P1/6 luminescent material for 24 hours;
图10为TPE-MEM(40μM)在水中的UV和PL光谱图,激发波长为405nm;Figure 10 is the UV and PL spectrum of TPE-MEM (40μM) in water, the excitation wavelength is 405nm;
图11A为TPE-MEM在含有不同含量的THF(fTHF)的THF/DMSO混合溶剂中的PL光谱图,其中TPE-MEM浓度为25μM,激发波长为405nm;Figure 11A is the PL spectrum of TPE-MEM in THF/DMSO mixed solvents containing different contents of THF (f THF ), wherein the concentration of TPE-MEM is 25 μM, and the excitation wavelength is 405 nm;
图11B为TPE-MEM在625nm的PL强度与THF/DMSO混合溶剂中的fTHF之间的相关曲线图,其中TPE-MEM浓度为25μM;内部的插图为TPE-MEM分别在DMSO溶剂和THF/DMSO混合溶剂(fTHF=99%)中由365nm波长的紫外光照射的照片;Figure 11B is the correlation curve between the PL intensity of TPE-MEM at 625nm and f THF in THF/DMSO mixed solvent, where the concentration of TPE-MEM is 25 μM; the inner inset is TPE-MEM in DMSO solvent and THF/DMSO Photographs irradiated by ultraviolet light with a wavelength of 365nm in DMSO mixed solvent ( fTHF =99%);
图12为TPE-MEM在600nm的PL强度与浓度之间的相关曲线图;内部的插图为不同浓度的TPE-MEM由365nm波长的紫外光照射的照片;Figure 12 is the correlation curve between the PL intensity and concentration of TPE-MEM at 600nm; the inner illustration is a photo of different concentrations of TPE-MEM irradiated by ultraviolet light with a wavelength of 365nm;
图13A为透射电子显微镜(TEM)测定的TPE-MEM(100μM)在水性溶液中的粒径照片;Figure 13A is a photo of the particle size of TPE-MEM (100 μM) in an aqueous solution measured by a transmission electron microscope (TEM);
图13B为电动电势粒度分析仪测定的不同浓度的TPE-MEM的粒径曲线图;内部的插图为由电动电势粒度分析仪测定的TPE-MEM(100μM)在水性溶液中的粒径分布图;Fig. 13B is a particle size curve diagram of TPE-MEM with different concentrations measured by a zeta potential particle size analyzer; the inner illustration is a particle size distribution diagram of TPE-MEM (100 μM) in an aqueous solution measured by a zeta potential particle size analyzer;
图14为MTT法测定的TPE-MEM对HeLa细胞增殖的影响的分析图;细胞暴露于不同浓度的TPE-MEM 6小时;Figure 14 is an analysis diagram of the influence of TPE-MEM measured by MTT method on the proliferation of HeLa cells; cells were exposed to different concentrations of TPE-MEM for 6 hours;
图15A为TPE-MEM(5μM,λex=405nm和λem=550±70nm)对HeLa细胞染色的激光扫描共聚焦显微镜成像图;Figure 15A is a laser scanning confocal microscope image of HeLa cells stained by TPE-MEM (5 μM, λ ex =405nm and λ em =550±70nm);
图15B为CellMaskTM深红色细胞膜染色剂(C10046,5μg/mL,λex=633nm和λem=685±55nm)对HeLa细胞染色的激光扫描共聚焦显微镜成像图;Figure 15B is a laser scanning confocal microscope image of HeLa cells stained by CellMask TM deep red cell membrane staining agent (C10046, 5 μg/mL, λ ex =633nm and λ em =685±55nm);
图15C为图15B相对应的明视野成像图;Fig. 15C is a bright field imaging diagram corresponding to Fig. 15B;
图15D为图15A-15C的合并成像图,图15A与图15B的重叠系数计算为72%;Fig. 15D is the merged imaging image of Fig. 15A-15C, and the overlapping coefficient of Fig. 15A and Fig. 15B is calculated to be 72%;
图16为随着扫描时间的增加过程中TPE-MEM(实线圆)荧光发射的信号损失(%)的变化曲线图;内部的插图分别为在325.7s连续扫描以前和连续扫描以后的由TPE-MEM(5μM)染色的活的HeLa细胞的荧光成像图,λex=405nm和λem=550±50nm;Fig. 16 is the change curve diagram of the signal loss (%) of TPE-MEM (solid line circle) fluorescence emission during the increase of scanning time; the inner illustrations are before and after the continuous scanning of 325.7s respectively by TPE -Fluorescence imaging of live HeLa cells stained with MEM (5 μM), λ ex =405nm and λ em =550±50nm;
图17A为存在有TPE-MEM(10μM)的H2DCFDA(1μM)在房间灯光照射下的PL光谱图,激发波长为488nm;Figure 17A is the PL spectrum of H2DCFDA (1 μM) in the presence of TPE-MEM (10 μM) under the illumination of room light, and the excitation wavelength is 488 nm;
图17B为照射时间分别对含有TPE-MEM的溶液、含有H2DCFDA的溶液或者TPE-MEM和H2DCFDA二者均含有的溶液在535nm的PL强度的影响的曲线图;17B is a graph showing the influence of irradiation time on the PL intensity at 535 nm of a solution containing TPE-MEM, a solution containing H2DCFDA, or a solution containing both TPE-MEM and H2DCFDA;
图18中的A-D照片为在照射前TPE-MEM和PI染色的HeLa细胞的共聚焦成像图;E-H照片为在照射后TPE-MEM和PI染色的HeLa细胞的共聚焦成像图;I-L照片为在照射后仅用PI染色的HeLa细胞的共聚焦成像图;C、G和K照片分别为A、E、I相对应的明视野的成像图;D、H和L分别是A/B/C的合并成像图、E/F/G的合并成像图和I/J/K的合并成像图;[TPE-MEM]=5μM;[PI]=3μM;Channel I:λex=405nm,λem=550±50nm;Channel II:λex=560nm,λem=620±65nm;Photos AD in Figure 18 are confocal imaging images of HeLa cells stained with TPE-MEM and PI before irradiation; photos EH are confocal imaging images of HeLa cells stained with TPE-MEM and PI after irradiation; photos IL are confocal imaging images of HeLa cells stained with TPE-MEM and PI after irradiation; Confocal images of HeLa cells stained with PI only after irradiation; photos C, G, and K are bright field images corresponding to A, E, and I; D, H, and L are images of A/B/C, respectively Combined imaging image, combined imaging image of E/F/G and combined imaging image of I/J/K; [TPE-MEM]=5 μM; [PI]=3 μM; Channel I: λ ex =405nm, λ em =550 ±50nm; Channel II: λ ex =560nm, λ em =620±65nm;
图19为通过MTT法测定房间灯光照射TPE-MEM以及未照射TPE-MEM分别对HeLa细胞增殖的影响的对比图;Figure 19 is a comparison chart of the effects of room light irradiation on TPE-MEM and non-irradiation of TPE-MEM on the proliferation of HeLa cells measured by the MTT method;
图20A为TPE-2Gd在不同含水量(fw)的THF/H2O混合溶液中由365nm的紫外光照射的照片;Figure 20A is a photo of TPE-2Gd irradiated by 365nm ultraviolet light in THF/H2O mixed solutions with different water contents (f w );
图20B为TPE-2Gd在不同含水量(fw)的THF/H2O混合溶液中的发射光谱图,浓度为100μM,激发波长为330nm;Figure 20B is the emission spectrum of TPE-2Gd in THF/H2O mixed solutions with different water contents (f w ), the concentration is 100 μM, and the excitation wavelength is 330 nm;
图20C为不同浓度TPE-2Gd(1μM and 100μM)的相对PL强度(I/I0)与THF/H2O混合溶液中的含水量之间的相关曲线图;Figure 20C is a graph showing the correlation between the relative PL intensity (I/I 0 ) of different concentrations of TPE-2Gd (1 μM and 100 μM) and the water content in the THF/H 2 O mixed solution;
图21A为不同浓度的TPE-2Gd水溶液在紫外光照射下的照片;Fig. 21A is the photograph of the TPE-2Gd aqueous solution of different concentrations under ultraviolet light irradiation;
图21B为不同浓度的TPE-2Gd水溶液的发射光谱图,激发波长为330nm;Figure 21B is an emission spectrum diagram of TPE-2Gd aqueous solutions with different concentrations, and the excitation wavelength is 330nm;
图21C为TPE-2Gd的PL强度与在水中的浓度之间的相关曲线图,TPE-2Gd的临界胶团浓度(CMC)为70μM;Figure 21C is a correlation curve between the PL intensity of TPE-2Gd and the concentration in water, and the critical micelle concentration (CMC) of TPE-2Gd is 70 μM;
图22A为TPE-2Gd(100μM)在水中的透射电子显微镜成像图;Figure 22A is a transmission electron microscope image of TPE-2Gd (100 μM) in water;
图22B为TPE-2Gd(100μM)在水中的粒径分析图;Figure 22B is a particle size analysis diagram of TPE-2Gd (100 μM) in water;
图23A为TPE-2Gd染色的HeLa细胞的荧光成像图,[TPE-2Gd]=30μM;Figure 23A is a fluorescence imaging image of HeLa cells stained with TPE-2Gd, [TPE-2Gd]=30 μM;
图23B为TPE-2Gd染色之后的PI染色的HeLa细胞的荧光成像图,[TPE-2Gd]=30μM;Figure 23B is a fluorescence imaging image of PI-stained HeLa cells after TPE-2Gd staining, [TPE-2Gd]=30 μM;
图23C为图23A与图23B的合并成像图,[TPE-2Gd]=30μM;Figure 23C is the merged image of Figure 23A and Figure 23B, [TPE-2Gd]=30μM;
图23D为HeLa细胞的明视野成像图,[TPE-2Gd]=30μM;Figure 23D is a bright field image of HeLa cells, [TPE-2Gd]=30 μM;
图24为通过MTT法测定的TPE-2Gd对HeLa细胞的细胞增殖情况的分析图,细胞暴露于不同浓度的TPE-2Gd 4小时,更换新鲜的培养基后继续培养24小时;Figure 24 is an analysis diagram of TPE-2Gd on the cell proliferation of HeLa cells measured by the MTT method. The cells were exposed to different concentrations of TPE-2Gd for 4 hours, and continued to culture for 24 hours after replacing the fresh medium;
图25为不同Gd3+浓度的TPE-2Gd和商用对照品的T1-加权核磁共振图谱(MR),样品由生理盐水进行稀释;Figure 25 is TPE-2Gd and commercial reference substances with different Gd 3+ concentrations The T 1 -weighted nuclear magnetic resonance spectrum (MR), the sample is diluted by normal saline;
图26为不同Gd3+浓度的TPE-2Gd和商用对照品的水质子纵向弛豫速率(1/T1)的曲线图,根据方程式:1/T1=1/T1,0+R1×[CGd],弛豫速度R1,TPE-2Gd=3.36±0.10mM-1·s-1;R1,magnevist=3.70±0.02mM-1·s-1;Figure 26 is TPE-2Gd and commercial reference substances with different Gd 3+ concentrations The graph of the water proton longitudinal relaxation rate (1/T 1 ), according to the equation: 1/T 1 =1/T 1,0 +R 1 ×[C Gd ], the relaxation rate R 1,TPE-2Gd = 3.36±0.10mM −1 ·s −1 ; R 1 , magnevist=3.70±0.02mM −1 ·s −1 ;
图27为分别给小鼠静脉注射含有G d3+离子浓度为0.1mmol/kg的TPE-2Gd和后的冠状的T1-加权核磁共振(MR)成像图;Figure 27 shows the intravenous injection of TPE- 2Gd and Post coronal T 1 -weighted magnetic resonance (MR) imaging image;
图28A为心脏的T1-加权成像的定量分析图;Figure 28A is a quantitative analysis graph of T1 - weighted imaging of the heart;
图28B为肝的T1-加权成像的定量分析图;Figure 28B is a quantitative analysis graph of T 1 -weighted imaging of the liver;
图29为分别给小鼠的肝内静脉注射含有G d3+离子浓度为0.1mmol/kg的TPE-2Gd和后的轴向的T1-加权核磁共振(MR)成像图。Figure 29 shows the intrahepatic intravenous injection of TPE- 2Gd and Post-axial T 1 -weighted magnetic resonance (MR) image.
具体实施方式Detailed ways
下面结合附图和实施例,对本发明的两亲性的具有聚集诱导发光特性的发光物及其应用作进一步说明:The amphiphilic luminescent substance with aggregation-induced luminescent properties and its applications of the present invention will be further described in conjunction with the accompanying drawings and examples:
在2001年由Tang发现了聚集诱导发光(aggregation-induced eimission,AIE)现象,目前AIE现象因其在有机发光二极管(OLEDs)、化学传感器、生物传感器以及体内外的生物成像剂等方面的潜在应用已经成为世界上最热研究领域之一,但大部分AIE分子都是由芳环构成,因此AIE分子呈疏水性,不溶于水性介质。另一方面,很少有报道关于水溶性AIE分子或两亲性AIE分子。从这方面考虑,本发明设计合成了一些水溶性和两亲性AIE分子,开发了它们的潜在生物应用。The aggregation-induced eimission (AIE) phenomenon was discovered by Tang in 2001. At present, the AIE phenomenon is due to its potential applications in organic light-emitting diodes (OLEDs), chemical sensors, biosensors, and biological imaging agents in vivo and in vitro. It has become one of the hottest research fields in the world, but most AIE molecules are composed of aromatic rings, so AIE molecules are hydrophobic and insoluble in aqueous media. On the other hand, there are few reports about water-soluble AIE molecules or amphiphilic AIE molecules. Considering this aspect, the present invention designs and synthesizes some water-soluble and amphiphilic AIE molecules, and develops their potential biological applications.
以下实施例仅是本发明的说明性的示例,而不是限制性的。The following examples are merely illustrative examples of the present invention, not restrictive.
实施例1:合成非离子两亲性的发光物P1/6、P2/6和P3/6并对其进行应用方面的实验研究Example 1: Synthesis of non-ionic amphiphilic luminescent substances P1/6, P2/6 and P3/6 and experimental research on their application
(1)合成(n、m、o和p分别表示2~3000的自然数)(1) Synthesis (n, m, o and p respectively represent natural numbers from 2 to 3000)
如图1所示,合成发光物P1/6所用的试剂的供给比例如下,第六化合物6、第一化合物1、CuBr和PMDETA之间的浓度比[6]/[1]/[CuBr]/[PMDETA]为1/4/4/4,合成发光物P2/6和P3/6的试剂的供给比例使用浓度的比例与发光物P1/6不同之处是第六化合物6分别与第二化合物2和第三化合物3的浓度比为[6]/[2]/[3]=1/1/0.5。室温下,在装有30mLDMF、CuBr(172mg,1.2mmol)和5.3mL PMDETA(1.2mmol)的50mL的Schlenk瓶中,第六化合物6(1.05mg,0.3mmol)和第一化合物1(430mg,1.2mmol)进行链接反应,进行搅拌36小时后,用水(300mL)将反应混合物稀释,用二氯甲烷对该水溶液提取四次,将所有有机相混合在一起,进一步由浓盐水冲洗六次,并通过Na2SO4干燥。溶剂蒸发后,残留物浓缩至~20mL,在乙醚(300mL)中沉淀3次,过滤沉淀物并用过量的乙醚冲洗得到相应的产物。As shown in Figure 1, the supply ratio of the reagents used in the synthesis of luminescent substance P1/6 is as follows, the concentration ratio between the sixth compound 6, the first compound 1, CuBr and PMDETA [6]/[1]/[CuBr]/ [PMDETA] is 1/4/4/4, the supply ratio of the reagents for synthesizing luminescent substances P2/6 and P3/6 is different from that of luminescent substance P1/6 in that the sixth compound 6 is different from the second compound The concentration ratio of 2 and the third compound 3 is [6]/[2]/[3]=1/1/0.5. At room temperature, the sixth compound 6 (1.05 mg, 0.3 mmol) and the first compound 1 (430 mg, 1.2 mmol) was carried out chain reaction, after stirring for 36 hours, the reaction mixture was diluted with water (300mL), the aqueous solution was extracted four times with dichloromethane, all the organic phases were mixed together, further washed six times by concentrated brine, and passed Na2SO4 dry . After solvent evaporation, the residue was concentrated to ~20 mL, precipitated three times in diethyl ether (300 mL), the precipitate was filtered and rinsed with excess diethyl ether to give the corresponding product.
发光物P1/6,产率82%,Mw 3200;Mw/Mn 1.03;IR(KBr),ν(cm-1):3435,2885,1641,1466,1346,1281,1244,1111,953,841,756,700,623,581,523;1HNMR(400MHz,DMSO-d6),δ(ppm):8.46(2H,s,苯三唑triazole-H),7.62(4H,d,J=8.0Hz,苯三唑triazole-Ar-H),7.17-6.99(34H,m,Ar-H),4.56(4H,t,J=4.8Hz,CH2-triazole苯三唑),3.85(4H,t,J=4.8Hz,CH2CH2-triazole苯三唑),3.53–3.46(300H,m,OCH2);13C NMR(100MHz,DMSO-d6),δ(ppm):145.86,143.15,143.02,142.63,140.77,140.19,131.20,130.70,130.65,128.97,127.86,127.82,126.62,124.50,121.72,72.36,69.90,69.73,69.64,68.67,60.23,49.58。Luminescent substance P1/6, yield 82%, M w 3200; M w /M n 1.03; IR (KBr), ν (cm -1 ): 3435, 2885, 1641, 1466, 1346, 1281, 1244, 1111, 953,841,756,700,623,581,523; 1 HNMR (400MHz, DMSO-d 6 ), δ (ppm): 8.46 (2H, s, benzotriazole triazole-H), 7.62 (4H, d, J = 8.0Hz, benzotriazole triazole-Ar- H), 7.17-6.99 (34H, m, Ar-H), 4.56 (4H, t, J = 4.8Hz, CH 2 -triazole benzotriazole), 3.85 (4H, t, J = 4.8Hz, CH 2 CH 2 -triazole (benzotriazole), 3.53–3.46 (300H, m, OCH 2 ); 13 C NMR (100MHz, DMSO-d 6 ), δ (ppm): 145.86, 143.15, 143.02, 142.63, 140.77, 140.19, 131.20 ,130.70,130.65,128.97,127.86,127.82,126.62,124.50,121.72,72.36,69.90,69.73,69.64,68.67,60.23,49.58.
发光物P2/6,产率81%,Mw 34700;Mw/Mn 1.39;IR(KBr),ν(cm-1):3416,2880,1639,1466,1352,1281,1250,1113,951,845,770,704,675,527;1HNMR(400MHz,DMSO-d6),δ(ppm):8.41(2H,s,triazole-H),7.57(4H,t,J=8.0Hz,苯三唑triazole-Ar-H),7.14-6.99(14H,m,Ar-H),4.50(4H,m,CH2-triazole苯三唑),3.80(4H,t,J=4.8Hz,OCH2CH2-triazole苯三唑),3.60–3.39(300H,m,OCH2);13C NMR(100MHz,DMSO-d6),δ(ppm):145.87,145.86,143.06,142.65,140.42,131.26,130.77,129.03,127.93,126.77,124.52,121.76,72.37,69.92,69.74,69.53,68.69.60.25,49.60。Luminescent substance P2/6, yield 81%, M w 34700; M w /M n 1.39; IR (KBr), ν (cm -1 ): 3416, 2880, 1639, 1466, 1352, 1281, 1250, 1113, 951,845,770,704,675,527; 1 HNMR (400MHz, DMSO-d 6 ), δ (ppm): 8.41 (2H, s, triazole-H), 7.57 (4H, t, J=8.0Hz, benzotriazole triazole-Ar-H), 7.14-6.99 (14H, m, Ar-H), 4.50 (4H, m, CH 2 -triazole), 3.80 (4H, t, J=4.8Hz, OCH 2 CH 2 -triazole), 3.60–3.39(300H,m,OCH 2 ); 13 C NMR(100MHz,DMSO-d 6 ),δ(ppm):145.87,145.86,143.06,142.65,140.42,131.26,130.77,129.03,127.93,126.72,124.5 ,121.76,72.37,69.92,69.74,69.53,68.69.60.25,49.60.
发光物P3/6,产率88%,Mw 27,600;Mw/Mn 1.39;IR(KBr),ν(cm-1):3439,3136,2873,1639,1463,1350,1286,1249,1109,954,840,663,530;1H NMR(400MHz,DMSO-d6),δ(ppm):8.41(4H,s,苯三唑triazole-H),7.61(8H,d,J=8.0Hz,苯三唑triazole-Ar-H),7.07(8H,d,J=8.0Hz,Ar-H),4.49(8H,s,CH2-triazole苯三唑),3.79(8H,s,OCH2CH2-triazole苯三唑),3.64–3.40(600H,m,OCH2);13C NMR(100MHz,DMSO-d6),δ(ppm):145.85,142.53,140.21,131.42,129.24,124.66,121.79,72.36,69.68,68.68,60.23,49.59。Luminescent substance P3/6, yield 88%, M w 27,600; M w /M n 1.39; IR (KBr), ν (cm -1 ): 3439, 3136, 2873, 1639, 1463, 1350, 1286, 1249, 1109,954,840,663,530; 1 H NMR(400MHz,DMSO-d 6 ),δ(ppm):8.41(4H,s,triazole-H),7.61(8H,d,J=8.0Hz,triazole -Ar-H), 7.07 (8H, d, J=8.0Hz, Ar-H), 4.49 (8H, s, CH 2 -triazole benzotriazole), 3.79 (8H, s, OCH 2 CH 2 -triazole benzene Triazole), 3.64–3.40 (600H, m, OCH 2 ); 13 C NMR (100MHz, DMSO-d 6 ), δ (ppm): 145.85, 142.53, 140.21, 131.42, 129.24, 124.66, 121.79, 72.36, 69.68 , 68.68, 60.23, 49.59.
(2)应用研究:(2) Applied research:
通过叠氮-炔的环加成作用合成带有不同链数聚乙二醇(PEG)的非离子的水溶性的四苯乙烯(TPE)-功能化的聚乙二醇(PEG)发光物(P1/6、P2/6和P3/6),将疏水性的TPE变成亲水分子。这些发光物显示出较好的热稳定性,参见表1,其中P1/6、P2/6和P3/6的Td分别为351.6℃、342.2℃和352.1℃。如图4A-4D所示,这些合成后的聚合物是水溶性和两亲性的,在THF/水溶剂系统和THF/己烷溶剂系统中均显示出AIE特性。在大量水溶液中,这些聚合物超过临界胶团浓度(CMC)时形成胶束聚合物。如图5A、5B和5C所示,通过利用这些聚合物聚集状态时自身荧光发光的性质得到P1/6、P2/6和P3/6的CMC分别为0.09mM、0.12mM和0.20mM,粒径分别约为100nm。所有结果表明,这些聚合物的胶束由在内侧的非极性的TPE头和指向水性介质的亲水性的PEG链组成。这些聚合物在CMC以下,则单独溶于介质中且不发光,当增加浓度至CMC以上时,这些聚合物开始形成胶束,TPE部分聚集在疏水内部,显示出较强的荧光发光。因此,由于分子内旋转的限制(restriction of intramolecular rotation,RIR)对胶束化的影响,这些聚合物变得可以发光。Synthesis of nonionic, water-soluble tetraphenylethylene (TPE)-functionalized polyethylene glycol (PEG) luminophores with different chain numbers of polyethylene glycol (PEG) via azide-alkyne cycloaddition ( P1/6, P2/6 and P3/6), to change the hydrophobic TPE into a hydrophilic molecule. These luminescent materials show good thermal stability, see Table 1, where the T d of P1/6, P2/6 and P3/6 are 351.6°C, 342.2°C and 352.1°C, respectively. As shown in Figures 4A–4D, these as-synthesized polymers are water-soluble and amphiphilic, and exhibit AIE characteristics in both THF/water solvent systems and THF/hexane solvent systems. In bulk aqueous solutions, these polymers form micellar polymers above the critical micelle concentration (CMC). As shown in Figures 5A, 5B and 5C, the CMCs of P1/6, P2/6 and P3/6 were 0.09mM, 0.12mM and 0.20mM respectively by utilizing the properties of autofluorescence in the aggregation state of these polymers. about 100nm, respectively. All the results indicated that the micelles of these polymers consisted of non-polar TPE heads on the inside and hydrophilic PEG chains directed towards the aqueous medium. Below the CMC, these polymers are soluble in the medium alone and do not emit light. When the concentration is increased above the CMC, these polymers begin to form micelles, and the TPE part gathers in the hydrophobic interior, showing strong fluorescence. These polymers thus become luminescent due to the effect of restriction of intramolecular rotation (RIR) on micellization.
为了研究P1/6对活细胞的影响,利用CCK8进行了细胞毒性分析。WST-8([2-(2-methoxy-4-nitropheny)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazoliun,monosodium salt],[2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-双磺苯基)-2H-四氮唑,谷氨酸钠盐]通过细胞内的脱氢酶转变为甲瓒,其与活细胞的数量成正比。如图6所示,P1/6的细胞毒性在P1/6暴露于HepG2细胞24h后呈剂量依赖性。浓度为50、75、100、125μg/mL所对应的细胞存活率分别为99.93%、98.1%、95.82%和92.94%,在浓度达到150μg/mL时,细胞存活率依然保持超过86%。所有数据表明P1/6具有用于活细胞成像的较好生物相容性。To investigate the effect of P1/6 on living cells, a cytotoxicity assay was performed using CCK8. WST-8([2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazoliun, monosodium salt], [2-(2-methyl Oxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, glutamate sodium salt] through intracellular The dehydrogenase is converted into formazan, which is proportional to the number of living cells. As shown in Figure 6, the cytotoxicity of P1/6 was dose-dependent after P1/6 was exposed to HepG2 cells for 24h. Concentrations were 50, 75 , 100, and 125 μg/mL corresponded to 99.93%, 98.1%, 95.82% and 92.94% cell viability respectively, and when the concentration reached 150 μg/mL, the cell survival rate still remained above 86%. All data show that P1/6 has Good biocompatibility for live cell imaging.
表1:P1/6、P2/6和P3/6的分子量以及热学性能Table 1: Molecular weight and thermal properties of P1/6, P2/6 and P3/6
作为药物载体用于临床应用方面,PEG是生物可相容的且适用于传递有机染色剂至细胞内。纯染色剂TPE因其高度疏水性无法透入进细胞内区域(未显示数据)。由于具有AIE性质的较佳的光学特性,使用TPE-功能化的PEG聚合物对贴壁型HepG2细胞染色作为生物探针。两亲性聚合物在水性溶液中倾向于形成纳米聚合物,其可以通过内吞作用促进细胞摄取。如图7所示,当HepG2细胞由P1/6染色12h时,从胞质区会发光。随着P1/6浓度的增加,荧光变得更强,表明内吞作用的效率取决于P1/6在培养基中的剂量。如图8所示,尽管细胞与高浓度的P2/6和P3/6进行培养更长的时间,但与P1/6相比发光要弱得多。这种差异归因于TPE与PEG之间的比例。For clinical applications as a drug carrier, PEG is biocompatible and suitable for delivering organic stains into cells. Pure stain TPE was unable to penetrate into intracellular regions due to its high hydrophobicity (data not shown). TPE-functionalized PEG polymers were used to stain adherent HepG2 cells as bioprobes due to better optical properties with AIE properties. Amphiphilic polymers tend to form nanopolymers in aqueous solution, which can facilitate cellular uptake through endocytosis. As shown in Figure 7, when HepG2 cells were stained by P1/6 for 12h, there was light from the cytoplasmic region. The fluorescence became stronger as the concentration of P1/6 increased, indicating that the efficiency of endocytosis depends on the dose of P1/6 in the medium. As shown in Figure 8, although the cells were incubated with high concentrations of P2/6 and P3/6 for a longer period of time, the luminescence was much weaker compared to P1/6. This difference is attributed to the ratio between TPE and PEG.
为了长时间监测细胞形态,生产商已经尽力改善染色后的负载时间。例如,商业细胞追踪器,CellTrackerTM蓝色CMAC(7-Amino-4-Chloromethylcoumarin,7-氨基-4-氯甲基香豆素)和蓝色CMHC(4-chloromethyl-7-hydroxycoumarin,4-氯甲基-7-羟基香豆素)由氯甲基官能团功能化。当追踪器的探针进入细胞内时,探针可以与蛋白质和多肽上的硫醇进行反应,但是根据协议染色剂在染色后仅可以照亮细胞大约24小时。如图9所示,作为第一代,活的HepG2细胞暴露于P1/6聚合物24小时,发出强光。由于在细胞内生物大分子PEG会锁住荧光团,细胞内的P1/6被传递至子细胞内。尽管增生代的增加使得荧光变弱,但是探针还是能够追踪至第五代。因此,P1/6可用作长期活细胞追踪器,是潜在的替代方式。因此,该荧光聚合物可应用于监测细胞内药物释放。In order to monitor cell morphology over a long period of time, manufacturers have tried to improve the loading time after staining. For example, commercial cell trackers, CellTracker TM blue CMAC (7-Amino-4-Chloromethylcoumarin, 7-amino-4-chloromethylcoumarin) and blue CMHC (4-chloromethyl-7-hydroxycoumarin, 4-chloro methyl-7-hydroxycoumarin) functionalized with chloromethyl functional groups. When the tracer's probes are inside the cells, the probes can react with thiols on proteins and peptides, but according to the protocol the stains only illuminate the cells for about 24 hours after staining. As shown in Figure 9, as the first passage, live HepG2 cells were exposed to P1/6 polymer for 24 hours, emitting strong light. Because the biological macromolecule PEG will lock the fluorophore in the cell, the P1/6 in the cell is delivered to the daughter cell. The probe was able to trace to the fifth generation, although the fluorescence became weaker due to the increase of the proliferative generation. Therefore, P1/6 can be used as a long-term live cell tracker, which is a potential alternative. Therefore, this fluorescent polymer can be applied to monitor intracellular drug release.
实施例2:合成阳离子两亲性的发光物TPE-MEM并对其进行应用方面的实验研究Example 2: Synthesis of cationic amphiphilic luminescent material TPE-MEM and experimental research on its application
(1)合成(1) synthesis
如图2所示,在氮气环境下,1-(3-三甲基胺基丙烷基)-4-甲基吡啶二溴化物(1-(3-trimethylammoniopropyl)-4-methylpyridinium dibromide)(0.5g,1.4mmol)和第三化合物3(1.5016g,2.8mmol)的溶液在无水乙醇中回流反应,加入三滴哌啶进行催化,冷却至室温后,在减压条件下蒸发溶剂,通过硅胶柱色谱法对残留物进行纯化,使用二氯甲烷和甲醇(2:1v/v)的混合溶剂作为洗脱剂,得到黄色产物TPE-MEM(0.72g,59%)。1H NMR(400MHz,甲醇-d4,δ):8.948(d,2H,J=6.8Hz),8.213-8.190(m,2H),7.946(6,1H,J=16Hz),7.737-7.717(m,2H),7.576(d,2H,J=8Hz),7.430-7.331(m,3H),7.061-6.843(m,14H),6.605-6.570(m,2H),4.698(t,2H,J=15.2Hz),3.797(t,2H,J=14.8Hz),3.644(t,2H,J=16.4Hz),3.240(s,9H),2.663-2.581(m,2H),1.693-1.619(m,2H),1.421-1.262(m,6H),0.871(t,3H,J=14.4Hz);13C NMR(100MHz,CDCl3,δ):157.362,157.260,153.875,143.411,143.306,143.250,143.227,143.198,141.993,140.990,140.597,138.760,136.680,135.055,133.295,131.619,131.584,131.140,130.482,128.135,126.902,126.855,126.798,126.683,126.281,125.676,125.507,125.457,125.216,125.115,123.440,121.585,112.874,112.700,66.856,61.787,55.965,52.066,30.728,30.716,28.311,24.791,24.216,21.625,12.399;HRMS(MALDI-TOF)m/z:计算值,791.3571[M-Br-]+;测定值,791.3570[M-Br-]+。As shown in Figure 2, under a nitrogen atmosphere, 1-(3-trimethylaminopropyl)-4-methylpyridine dibromide (1-(3-trimethylammoniopropyl)-4-methylpyridinium dibromide) (0.5g , 1.4mmol) and the third compound 3 (1.5016g, 2.8mmol) were refluxed in absolute ethanol, and three drops of piperidine were added for catalysis. After cooling to room temperature, the solvent was evaporated under reduced pressure and passed through a silica gel column. The residue was purified by chromatography using a mixed solvent of dichloromethane and methanol (2:1 v/v) as eluent to give a yellow product TPE-MEM (0.72 g, 59%). 1 H NMR (400MHz, methanol-d 4 ,δ): 8.948 (d, 2H, J = 6.8Hz), 8.213-8.190 (m, 2H), 7.946 (6, 1H, J = 16Hz), 7.737-7.717 ( m,2H),7.576(d,2H,J=8Hz),7.430-7.331(m,3H),7.061-6.843(m,14H),6.605-6.570(m,2H),4.698(t,2H,J =15.2Hz), 3.797(t, 2H, J=14.8Hz), 3.644(t, 2H, J=16.4Hz), 3.240(s, 9H), 2.663-2.581(m, 2H), 1.693-1.619(m ,2H),1.421-1.262(m,6H),0.871(t,3H,J=14.4Hz); 13 C NMR(100MHz,CDCl 3 ,δ):157.362,157.260,153.875,143.411,143.306,143.250,143.227 ,143.198,141.993,140.990,140.597,138.760,136.680,135.055,133.295,131.619,131.584,131.140,130.482,128.135,126.902,126.855,126.798,126.683,126.281,125.676,125.507,125.457,125.216,125.115,123.440,121.585 , 112.874, 112.700, 66.856, 61.787, 55.965, 52.066, 30.728, 30.716, 28.311, 24.791, 24.216, 21.625 , 12.399 ; Value, 791.3570[M-Br - ] + .
(2)应用研究(2) Applied research
细胞膜为细胞的保护屏障,对于细胞的完整性、生长和死亡至关重要。迫切需要在活细胞和濒死细胞内对细胞膜成像的发光物。在本实施例中提供一种新的两亲性以四苯乙烯为基础的吡啶盐(tetraphenylethene-basedpyridinium salt,TPE-MEM),具有显著的聚集诱导发光(AIE)特性,并用于选择性细胞膜染色。该高产率的发光物的荧光探针(TPE-MEM)通过下述反应合成,包括不对称McMurry反应、Suzuki耦合反应以及带双电荷的吡啶盐和己氧基四苯乙烯苯甲醛(hexyloxytetraphenylethene benzaldehyde)之间的缩合反应。由于双电荷特性,TPE-MEM在非极性溶剂中具有较差的溶解性,如在THF和DCM非极性溶剂中,但在极性溶剂中可溶,如在水、DMF、DMSO和甲醇中可溶。The cell membrane is the cell's protective barrier and is essential for cell integrity, growth, and death. Luminescents that image cell membranes in living and dying cells are urgently needed. In this example, a novel amphiphilic tetraphenylethene-based pyridinium salt (tetraphenylethene-basedpyridinium salt, TPE-MEM) with remarkable aggregation-induced emission (AIE) properties and used for selective cell membrane staining is provided . The high-yield luminescent fluorescent probe (TPE-MEM) was synthesized by the following reactions, including asymmetric McMurry reaction, Suzuki coupling reaction and doubly charged pyridinium salt and hexyloxytetraphenylethene benzaldehyde (hexyloxytetraphenylethene benzaldehyde) condensation reaction between them. Due to the double charge characteristics, TPE-MEM has poor solubility in non-polar solvents, such as in THF and DCM non-polar solvents, but soluble in polar solvents, such as in water, DMF, DMSO and methanol Soluble in.
图10显示了TPE-MEM在水性溶液(40μM)中的紫外(UV)和光致发光(PL)光谱。TPE-MEM的吸收最大波长落在395nm。为了方便生物应用,使用405nm作为激发波长进行PL测定。水性溶液的光激发诱导在590nm发黄光,表示发生了185nm的大量位移,这是由扩展共轭作用以及从电子供体TPE配基至电子受体吡啶单元的分子内电荷转移(intramolecularcharge transfer,ICT)造成的。Figure 10 shows the ultraviolet (UV) and photoluminescence (PL) spectra of TPE-MEM in aqueous solution (40 μΜ). The absorption maximum wavelength of TPE-MEM falls at 395nm. For the convenience of biological applications, PL measurements were performed using 405 nm as the excitation wavelength. Photoexcitation of the aqueous solution induced yellow emission at 590 nm, indicating a large shift at 185 nm, caused by extended conjugation and intramolecular charge transfer from the electron donor TPE ligand to the electron acceptor pyridine unit (intramolecular charge transfer, ICT).
如图11A和11B所示,TPE-MEM显示出明显相反的AIE性质,这是由于其强极性的性质导致的。TPE-MEM(25μM)的DMSO溶液发光较弱,而在含量99%的THF中,在625nm发光变强。考虑到TPE-MEM的分子结构,推测两亲性TPE-MEM分子在高浓度情况下可以形成胶团。得益于AIE的性质,TPE-MEM的临界胶团浓度(CMC)可以利用其自身的荧光强度进行测定。如图12所示,TPE-MEM的浓度在CMC以下时是分子溶解,因此不产生荧光;在0.01mM以上,PL强度急剧增强;PL强度与染色剂浓度之间的相关曲线产生两条线,两条线的交叉点确定CMC为0.02mM。如图13A和13B所示,通过透射电子显微镜和电动电势粒度分析仪也证实了在高染色剂浓度中纳米聚合物的形成以及CMC值。含水胶束的有效直径为77.4nm,随着脱水有效直径缩减到40nm。当TPE-MEM在CMC以下是分子溶解的时候,不能检测到微粒;当在CMC(0.02mM)以上时,可以观察到微粒。由PL测定的曲折点与CMC值相同。此外,纳米聚合物的粒径既适合于体外细胞摄取和体内循环,又适合于生物分布。As shown in Figures 11A and 11B, TPE-MEM exhibited clearly opposite AIE properties due to its strongly polar nature. The DMSO solution of TPE-MEM (25μM) emits weakly, but in 99% THF, the luminescence becomes stronger at 625nm. Considering the molecular structure of TPE-MEM, it is speculated that the amphiphilic TPE-MEM molecules can form micelles at high concentrations. Thanks to the properties of AIE, the critical micelle concentration (CMC) of TPE-MEM can be determined using its own fluorescence intensity. As shown in Figure 12, when the concentration of TPE-MEM is below the CMC, the molecule dissolves, so no fluorescence is produced; above 0.01mM, the PL intensity increases sharply; the correlation curve between the PL intensity and the concentration of the dye produces two lines, The intersection of the two lines determines the CMC to be 0.02 mM. As shown in Figures 13A and 13B, the formation of nanopolymers and CMC values at high dye concentrations were also confirmed by transmission electron microscopy and zeta potential particle size analyzer. The effective diameter of the aqueous micelles is 77.4nm, and the effective diameter shrinks to 40nm with dehydration. When TPE-MEM is molecularly dissolved below the CMC, no microparticles can be detected; when above the CMC (0.02mM), microparticles can be observed. The inflection point determined by PL is the same as the CMC value. In addition, the particle size of nanopolymers is suitable for both in vitro cellular uptake and in vivo circulation, as well as biodistribution.
在细胞成像以前,利用MTT比色法在HeLa细胞内可以测定TPE-MEM的细胞活性和细胞毒性。在37℃条件下,在黑暗的CO2培养器内细胞暴露于不同浓度(0、2.5μM、5μM、10μM、20μM)的TPE-MEM 6小时,然后在培养器的新鲜的培养基内再培养18小时进行细胞增殖。如图14所示,结果显示在黑暗中TPE-MEM的浓度即使达到20μM也一般没有细胞毒性。然后正如预期的,对TPE-MEM用于选择性的细胞膜染色进行评估。如图15A-15D所示,使用CellMaskTM Deep Red细胞膜染色剂(C10046)进行的联合染色实验表明从TPE-MEM观察到的荧光是来自于活的HeLa细胞的细胞膜,其中该细胞膜染色剂是一种商业上可获得的细胞膜成像剂。通过使用共聚焦显微镜(CLSM LSM7;Carl Zeiss,Germany)的软件,测定图15A和图15B之间的重叠系数为72%。重叠系数相当高,这是由于薄层细胞膜结构以及两种染色剂之间的竞争抑制。与C10046相比,TPE-MEM显示出较少的内在化作用,且对细胞膜的成像表现出较好的成像分辨率。更甚地,通过TPE-MEM还可以清楚地看到细胞微绒毛。除了复合染色实验,还进行了Z型CLSM扫描(Z-stack CLSM scanning)。Cell viability and cytotoxicity of TPE-MEM can be measured in HeLa cells using MTT colorimetry prior to cell imaging. At 37°C, cells were exposed to different concentrations (0, 2.5 μM, 5 μM, 10 μM, 20 μM) of TPE-MEM for 6 hours in a dark CO2 incubator, and then cultured in fresh medium in the incubator for 18 hours. hours for cell proliferation. As shown in Fig. 14, the results show that TPE-MEM concentrations up to 20 μM are generally not cytotoxic in the dark. TPE-MEM was then evaluated for selective membrane staining, as expected. As shown in Figures 15A-15D, co-staining experiments using CellMask ™ Deep Red cell membrane stain (C10046), which is a A commercially available cell membrane imaging agent. By using software for a confocal microscope (CLSM LSM7; Carl Zeiss, Germany), the overlap factor between Figure 15A and Figure 15B was determined to be 72%. The overlap factor is quite high due to the thin cell membrane structure and competitive inhibition between the two stains. Compared to C10046, TPE-MEM showed less internalization and imaged cell membranes with better imaging resolution. What's more, cell microvilli can be clearly seen through TPE-MEM. In addition to compound staining experiments, Z-stack CLSM scanning was also performed.
细胞膜是在膜的界面上显示较大负电位的细胞器,在该细胞器上磷脂双分子层主要由薄的两亲性磷脂双分子层构成。因此,细胞膜目标生物染色剂通常需要符合是两亲性的和阳离子的。协调平衡分子的疏水性和亲水性以满足细胞膜的两亲性,这对于设计新的细胞膜生物染色剂至关重要。TPE-MEM具有两亲性和带正荷的特性,因此将其可以作为极佳的生物染色剂,用于特异性染色活细胞的细胞膜。两亲性的TPE-MEM自发排列在磷脂双层,以便使疏水尾部区域在与周围极性液体相隔离的双层内以及亲水头部区域被静电吸引至负电荷的磷酸盐。如静电作用力和范德瓦尔斯相互作用力(van der Waals interactions)等导致特异性目标染色。A cell membrane is an organelle showing a large negative potential at the interface of the membrane, and the phospholipid bilayer on this organelle is mainly composed of a thin amphipathic phospholipid bilayer. Therefore, cell membrane target biostains generally need to be both amphipathic and cationic. Coordinating and balancing the hydrophobicity and hydrophilicity of molecules to meet the amphipathic nature of cell membranes is crucial for the design of new biostains for cell membranes. TPE-MEM is amphiphilic and positively charged, so it can be used as an excellent biological stain to specifically stain the cell membrane of living cells. The amphiphilic TPE-MEM is spontaneously arranged in the phospholipid bilayer such that the hydrophobic tail region is electrostatically attracted to the negatively charged phosphate within the bilayer and the hydrophilic head region is isolated from the surrounding polar liquid. Forces such as electrostatic forces and van der Waals interactions (van der Waals interactions) lead to specific target staining.
对于细胞成像染色剂,耐光性是最重要的标准之一。用于特异性细胞染色的一些AIE染色剂都是高耐光性的。螺旋状分子结构和其聚合形成过程可以阻止氧气扩散进入AIE微粒内,氧气进入AIE微粒内会氧化荧光团以及使其PL发光变白。如图16所示,在活细胞内得到了相似的耐光性结果。根据初始荧光强度标准化荧光强度。如图16所示,总照射时间5分钟(30次扫描),TPE-MEM的信号损失少于40%。从0s至325.7s的时间,信号损失和成像亮度发生轻微下降,这是由于染色剂的扩散以及细胞的移动。For cell imaging stains, photostability is one of the most important criteria. Some AIE stains used for specific cell staining are highly photostable. The helical molecular structure and its polymerization formation process can prevent the diffusion of oxygen into the AIE particles, and the oxygen entering into the AIE particles will oxidize the fluorophore and make its PL emission white. As shown in Figure 16, similar photostability results were obtained in living cells. Normalize the fluorescence intensity based on the initial fluorescence intensity. As shown in Figure 16, the signal loss of TPE-MEM was less than 40% with a total irradiation time of 5 minutes (30 scans). From 0 s to 325.7 s, there is a slight drop in signal loss and imaging brightness due to diffusion of the stain and movement of the cells.
如图16所示,在CLSM时间过程中系列扫描中可以看到气泡。明显地,细胞绒毛收缩并消失,然后基于激光扫描,细胞膨胀并泄露,可见细胞质膜变得不连续且是渗漏的。这种现象强烈表明细胞死亡是由激光扫描导致的,这就激发了人们后续研究的原因。在π-共轭体系中具有正电荷的吩噻嗪(phenothiazinium)基分子广泛用于活性氧(ROS)生成和光线疗法。与吩噻嗪相比,TPE-MEM在π-共轭体系中也具有正电荷,这有可能会使得光诱导ROS生成,导致细胞死亡。As shown in Figure 16, bubbles can be seen in the series of scans over the CLSM time course. Apparently, the cell villi shrank and disappeared, and then based on laser scanning, the cells swelled and leaked, showing that the plasma membrane of the cells became discontinuous and leaky. This phenomenon strongly suggested that the cell death was caused by laser scanning, which is why the follow-up research was motivated. Phenothiazinium-based molecules with positive charges in π-conjugated systems are widely used in reactive oxygen species (ROS) generation and phototherapy. Compared with phenothiazine, TPE-MEM also has a positive charge in the π-conjugated system, which may allow light-induced ROS generation, resulting in cell death.
为了证实上述假设,使用商用ROS荧光探针H2DCFDA进行ROS检测。当通过已存在的ROS氧化H2DCFDA时,可以检测到在535nm(λex=488nm)发射强荧光。出人意外地,正常的白色房间灯光(LED灯泡,3W)照射到TPE-MEM溶液时足够产生ROS。含有H2DCFDA的PBS溶液、含有TPE-MEM的PBS溶液以及同时含有H2DCFDA和TPE-MEM的PBS溶液的PL光谱都是在相同的房间灯光照射得到的。记录样品不同照射时间的PL光谱(图17A,λex=488nm)以及535nm的峰值强度与照射时间之间的相关曲线(图17B)。在图17A中,当溶液中同时存在H2DCFDA和TPE-MEM时,被氧化的H2DCFDA在535nm的特征峰出现并随着光照射增强。测定结果显示即使房间灯光照射时间超过120分钟,PL强度仍然持续增强,而紫外光照射仅几分钟之内就使荧光变白(未显示数据)。单独的H2DCFDA溶液和单独的TPE-MEM溶液由房间灯光照射后的PL强度变化轻微。观察结果表明实际上是光线照射在TPE-MEM的时候产生的ROS,导致细胞受损和死亡。To confirm the above hypothesis, ROS detection was performed using a commercial ROS fluorescent probe H2DCFDA. When H2DCFDA is oxidized by pre-existing ROS, strong fluorescence emission at 535 nm (λ ex =488 nm) can be detected. Surprisingly, normal white room light (LED bulb, 3W) was sufficient to generate ROS when irradiated on the TPE-MEM solution. The PL spectra of the PBS solution containing H2DCFDA, the PBS solution containing TPE-MEM, and the PBS solution containing both H2DCFDA and TPE-MEM were obtained in the same room illuminated by light. The PL spectra of the samples at different irradiation times were recorded ( FIG. 17A , λ ex =488nm) and the correlation curve between the peak intensity at 535nm and the irradiation time ( FIG. 17B ). In FIG. 17A , when H2DCFDA and TPE-MEM exist in the solution simultaneously, the characteristic peak of oxidized H2DCFDA appears at 535 nm and increases with light irradiation. The measurement results showed that the PL intensity continued to increase even when the room light was irradiated for more than 120 min, while the UV light whitened the fluorescence within only a few minutes (data not shown). The PL intensity of H2DCFDA solution alone and TPE-MEM solution alone changed slightly after being irradiated by room light. The observations showed that it was actually ROS generated when the light irradiated the TPE-MEM, causing cell damage and death.
然而,细胞死亡的病理学仍然无法解释。细胞膜的完整性是最重要形态学特征之一,用于区分细胞凋亡和细胞坏死。在细胞坏死的过程中,细胞膨胀,细胞膜变得有漏洞并分裂,最终细胞与周围环境交换物质。碘化丙啶(propidium iodide,PI)是不能渗透通过细胞膜的,通常排除在活细胞之外。当细胞膜有漏洞时,PI常用于对死亡细胞的胞核染色。因此,PI开放用于在大量细胞中识别死亡细胞并在多色荧光技术中作为复染色剂。在本实例中,如图18所示,TPE-MEM加入至具有活细胞的培养基内进行标记,然后将PI引入至观察基内。如图18中的A-D所示,在光照射以前仅可以检测到来自于细胞膜上的TPE-MEM(channel I)的黄光。当照射细胞约5分钟(30scans)的时候,再照射另一个5分钟用于摄取PI,如图18中的E-H所示,在细胞内部的细胞质和细胞核内可以观察到细胞形态的变化以及来自于PI(channel II)所发的红光。在细胞核内来自于PI所发的红光是由于PI插入结合至DNA导致PI发红光,而细胞质内的红色信号有可能是细胞核裂解进入至细胞质内造成的。在没有TPE-MEM的控制实验中,在照射前(未显示数据)和照射后(图18中的I-L)都没有检测到红色信号(channel II)。所有观察结果显示细胞膜变得有漏洞,表明在存在有TPE-MEM的情况下进行光线照射会引起细胞坏死。However, the pathology of cell death remains unexplained. Cell membrane integrity is one of the most important morphological features used to differentiate apoptosis from necrosis. During necrosis, the cell swells, the cell membrane becomes porous and splits, and eventually the cell exchanges material with its surroundings. Propidium iodide (PI) is impermeable through cell membranes and is generally excluded from living cells. PI is often used to stain the nuclei of dead cells when the cell membrane is porous. Thus, PI opens up for the identification of dead cells in large numbers of cells and as a counterstain in multicolor fluorescence techniques. In this example, as shown in Figure 18, TPE-MEM was added to the culture medium with living cells for labeling, and then PI was introduced into the observation base. As shown in A-D of Figure 18, only yellow light from TPE-MEM (channel I) on the cell membrane could be detected before light irradiation. When the cells were irradiated for about 5 minutes (30scans), and then irradiated for another 5 minutes for PI uptake, as shown in E-H in Figure 18, changes in cell morphology could be observed in the cytoplasm and nucleus inside the cells and from Red light emitted by PI (channel II). The red light emitted by PI in the nucleus is due to the insertion and binding of PI to DNA, which causes PI to emit red light, while the red signal in the cytoplasm may be caused by the cleavage of the nucleus into the cytoplasm. In the control experiment without TPE-MEM, no red signal (channel II) was detected before irradiation (data not shown) and after irradiation (I–L in Fig. 18). All observations showed that the cell membrane became porous, indicating that light exposure in the presence of TPE-MEM caused cell necrosis.
所有结果表明TPE-MEM在房间灯光照射下促使产生ROS。TPE-MEM除了具有细胞膜选择性和极好的耐光性,TPE-MEM可潜在用作治疗癌症的光线疗法药物。为了评估利用正常房间灯光照射TPE-MEM的光线疗法对HeLa癌细胞增殖的影响,如图19所示,通过MTT法,对于房间灯光照射2小时和未照射2小时两种情况分别测定含有不同浓度的TPE-MEM的细胞存活率。通过测定的MTT值与不含有TPE-MEM且未光照的样品测得的MTT值之间的关系制备标准曲线进而计算细胞存活率。All the results indicated that TPE-MEM promoted ROS generation under room light irradiation. In addition to the membrane selectivity and excellent photostability of TPE-MEM, TPE-MEM can be potentially used as a phototherapy drug for cancer treatment. In order to evaluate the effect of light therapy on the proliferation of HeLa cancer cells by using normal room light to irradiate TPE-MEM, as shown in Figure 19, by the MTT method, two conditions containing different concentrations of Cell viability of TPE-MEM. A standard curve was prepared from the relationship between the measured MTT value and the measured MTT value of the sample not containing TPE-MEM and not illuminated, and then the cell viability was calculated.
图19的结果显示未经照射的细胞是有存活率且从0μM-10μM的细胞存活率约为90%,不含有TPE-MEM的样品经房间灯光照射后未显示毒性。然而,经房间灯光照射的TPE-MEM产生ROS,在含有10μM的TPE-MEM的细胞存活率降至47%。在含有TPE-MEM的情况下,经房间灯光照射的样品与未经房间灯光照射的样品之间得到比较大的细胞存活率差异。白色房间灯光照射是温和的,容易获得且便宜,结合产生ROS的高产率,使得光线疗法无危害性、耐光、暗毒性低。所有的优点使得TPE-MEM是一种较好的光敏剂(也可以称为感光剂)。The results in Figure 19 show that the unirradiated cells have a survival rate and the cell survival rate from 0 μM-10 μM is about 90%, and the sample without TPE-MEM shows no toxicity after being irradiated by room light. However, TPE-MEM irradiated with room light produced ROS, and the cell viability dropped to 47% in the TPE-MEM containing 10 μM. In the case of containing TPE-MEM, a relatively large difference in cell viability was obtained between samples irradiated with room light and samples not irradiated with room light. White room lighting is mild, readily available, and cheap, which, combined with high yields of ROS, makes phototherapy non-hazardous, photostable, and low in dark toxicity. All the advantages make TPE-MEM a better photosensitizer (also called photosensitizer).
即使很难鉴定ROS物质以及说明ROS产生的机制,但却可以观察到ROS的产生。ROS已经显示出可以增强癌细胞的增殖,但过量的ROS水平会导致癌细胞凋亡和坏死。在本实例中,细胞膜生物染色剂(TPE-MEM)通过房间灯光照射产生过量的ROS,可以实时地可视化原位癌细胞坏死的过程。Although it is difficult to identify ROS substances and explain the mechanism of ROS generation, ROS generation can be observed. ROS have been shown to enhance the proliferation of cancer cells, but excessive ROS levels can lead to apoptosis and necrosis of cancer cells. In this example, cell membrane biostain (TPE-MEM) generates excess ROS by room light irradiation, which can visualize the process of necrosis of cancer cells in situ in real time.
总之,合成的具有强AIE特性的非对称的两亲性的四苯乙烯基吡啶盐(tetraphenylethene-based pyridinium salt,TPE-MEM)可用于细胞膜染色。由于阳离子和两亲性,TPE-MEM对细胞膜具有高特异性以及在活细胞内具有极佳的耐光性。令人意外的是,仅通过普通房间灯光照射下TPE-MEM就可以有效诱导产生ROS,导致细胞坏死。这些独特特征使得可以实时观察在原位的细胞坏死的过程和光线疗法的过程。因此,产生ROS和可光线疗法的结果使得本实施例的发光物可用于制备治疗癌症的新的AIE光线疗法药物。In conclusion, the synthesized asymmetric amphiphilic tetraphenylethene-based pyridinium salt (TPE-MEM) with strong AIE properties can be used for cell membrane staining. Due to the cationic and amphiphilic properties, TPE-MEM has high specificity for cell membranes and excellent photostability in living cells. Surprisingly, TPE-MEM can effectively induce ROS and lead to cell necrosis only by ordinary room light irradiation. These unique features allow real-time observation of the process of necrosis and phototherapy in situ. Therefore, the result of generating ROS and phototherapy makes the luminescent material of this embodiment can be used to prepare new AIE phototherapy drugs for treating cancer.
实施例3:合成阴离子的两亲性发光物TPE-2Gd并对其进行应用方面的实验研究Example 3: Synthesis of anionic amphiphilic luminescent material TPE-2Gd and experimental research on its application
(1)合成TPE-2+(1) Synthesis of TPE-2+
如图3所示,在氮气环境下,1-(3-三甲基胺基丙烷基)-4-甲基吡啶二溴化物(1-(3-trimethylammoniopropyl)-4-methylpyridinium dibromide)(0.5g,1.4mmol)和4-(1,2,2-三苯基乙烯基)苯甲醛(4-(1,2,2-triphenylvinyl)benzaldehyde)(1.01g,2.8mmol)的溶液在无水甲醇中回流反应,加入三滴哌啶进行催化,冷却至室温后,在减压条件下蒸发溶剂,通过硅胶柱色谱法对残留物进行纯化,使用二氯甲烷和甲醇(2:1v/v)的混合溶剂作为洗脱剂,得到黄色产物TPE-2+(0.56g,57%)。1H NMR(400MHz,甲醇-d4,δ):8.913(d,2H,J=6.8Hz),8.177(d,2H,J=6.8Hz),7.875(d,1H,J=16.0Hz),7.501(d,2H,J=8.4Hz),7.352(d,1H,J=16.4Hz),7.120-6.985(m,17H),4.678(t,2H,J=12.4Hz),3.611(t,2H,J=16.8Hz),3.224(s,9H),2.600(m,2H);13C NMR(100MHz,甲醇-d4,δ):153.985,146.064,143.359,142.763,142.666,142.535,141.710,141.079,139.581,132.603,131.121,130.342,130.261,126.910,126.741,125.901,125.794,123.366,121.556,61.776,55.939,52.015,24.136;HRMS(MALDI-TOF)m/z:计算值,535.3102[M-HBr-Br-]+;测定值,537.3263[M-HBr-Br-]+。As shown in Figure 3, under nitrogen atmosphere, 1-(3-trimethylaminopropyl)-4-methylpyridine dibromide (1-(3-trimethylammoniopropyl)-4-methylpyridinium dibromide) (0.5g , 1.4mmol) and 4-(1,2,2-triphenylvinyl)benzaldehyde (4-(1,2,2-triphenylvinyl)benzaldehyde) (1.01g, 2.8mmol) in anhydrous methanol Reflux reaction, add three drops of piperidine for catalysis, after cooling to room temperature, evaporate the solvent under reduced pressure, and purify the residue by silica gel column chromatography, using a mixture of dichloromethane and methanol (2:1v/v) The solvent was used as eluent to give the yellow product TPE-2+ (0.56 g, 57%). 1 H NMR (400MHz, methanol-d 4 ,δ): 8.913 (d, 2H, J = 6.8Hz), 8.177 (d, 2H, J = 6.8Hz), 7.875 (d, 1H, J = 16.0Hz), 7.501(d, 2H, J=8.4Hz), 7.352(d, 1H, J=16.4Hz), 7.120-6.985(m, 17H), 4.678(t, 2H, J=12.4Hz), 3.611(t, 2H , J=16.8Hz), 3.224(s,9H), 2.600(m,2H); 13 C NMR (100MHz, methanol-d 4 ,δ): 153.985, 146.064, 143.359, 142.763, 142.666, 142.535, 141.710, 141.079 ,139.581,132.603,131.121,130.342,130.261,126.910,126.741,125.901,125.794,123.366,121.556,61.776,55.939,52.015,24.136;HRMS(MALDI-TOF)m/z:计算值,535.3102[M-HBr- Br - ] + ; measured value, 537.3263[M-HBr-Br - ] + .
(2)合成第五化合物5,并通过第五化合物5合成TPE-2Gd(2) Synthesize the fifth compound 5, and synthesize TPE-2Gd through the fifth compound 5
如图3所示,将第三化合物3(163.3mg,0.2mmol)、第四化合物4(214.4mg,0.6mmol)、DCC(136.2mg,0.66mmol)和DMAP(80.6mg,0.66mmol)完全溶解于30mL的DMF中,加入3mL的三乙胺后,室温条件下,在氮气环境下对上述混合物搅拌48小时,搅拌后的混合物中加入10mL的三氟乙酸酸化30分钟,然后过滤,在己烷中沉淀3次,得到相应的需要的第五化合物5,产率92%。1H NMR(400MHz,DMSO-d6,δ):8.45(m,2H,H oftriazole苯三唑),8.05(m,2H,H of amide酰胺),7.60(m,4H;H-Ar-triazole苯三唑),7.12-7.01(m,14H;H-Ar),4.53(s,4H;CH2-triazole苯三唑),3.83(m,4H;CH2C-triazole苯三唑),3.57-3.13(m,20H;OCH2),3.02(s,20H;CH2C=O),2.90(s,20H;NCH2);13C NMR(100MHz,DMSO-d6,δ):172.6,169.2,145.9,143.0,142.6,140.4,131.3,130.7,129.0,127.9,126.7,124.6,121.8,69.6,68.6,64.9,55.1,51.7,49.6;IR(KBr):ν=3437.2,2954.9,1726.3,1635.6,1460.1,1396.4,1226.7,1089.8,974.1,908.5,700.2cm-1;HRMS(MALDI-TOF)m/z:计算值,1670.5896[M-4H+3Na+K];测定值,1669.1871[M-5H+3Na+K]+;计算值,1698.5795[M-6H+6Na];测定值,1697.1949[M-7H+6Na]+;计算值,1724.8194;[M-5H+2Na+3K];测定值,1724.2223[M-6H+2Na+3K]+。As shown in Figure 3, the third compound 3 (163.3mg, 0.2mmol), the fourth compound 4 (214.4mg, 0.6mmol), DCC (136.2mg, 0.66mmol) and DMAP (80.6mg, 0.66mmol) were completely dissolved After adding 3 mL of triethylamine to 30 mL of DMF, the above mixture was stirred for 48 hours under nitrogen atmosphere at room temperature, and 10 mL of trifluoroacetic acid was added to the stirred mixture to acidify for 30 minutes, then filtered, and dissolved in hexane Precipitation in 3 times, the corresponding required fifth compound 5 was obtained with a yield of 92%. 1 H NMR (400MHz, DMSO-d 6 ,δ): 8.45(m,2H,H oftriazole), 8.05(m,2H,H of amide), 7.60(m,4H; H-Ar-triazole Benzenetriazole), 7.12-7.01(m, 14H; H-Ar), 4.53(s, 4H; CH 2 -triazole benzotriazole), 3.83(m, 4H; CH 2 C-triazole benzotriazole), 3.57 -3.13 (m, 20H; OCH 2 ), 3.02 (s, 20H; CH 2 C=O), 2.90 (s, 20H; NCH 2 ); 13 C NMR (100MHz, DMSO-d 6 , δ): 172.6, 169.2, 145.9, 143.0, 142.6, 140.4, 131.3, 130.7, 129.0, 127.9, 126.7, 124.6, 121.8, 69.6, 68.6, 64.9, 55.1, 51.7, 49.6; , 1460.1, 1396.4, 1226.7, 1089.8, 974.1, 908.5, 700.2cm -1 ; HRMS (MALDI-TOF) m/z: calculated value, 1670.5896[M-4H+3Na+K]; measured value, 1669.1871[M-5H +3Na+K] + ; calculated value, 1698.5795[M-6H+6Na]; measured value, 1697.1949[M-7H+6Na] + ; calculated value, 1724.8194; [M-5H+2Na+3K]; measured value, 1724.2223[M-6H+2Na+3K] + .
如图3所示,然后将第五化合物5(235.0mg,0.15mmol)、GdAc3(107.0mg,0.32mmol)和NaAc(131.2mg,1.6mmol)溶解于20mL的DMF中,在70℃条件下搅拌过夜后,对得到的混合物过滤,在己烷中沉淀三次,得到相应的所需化合物TPE-2Gd,产率95%。IR(KBr):ν=3439.1,1595.1,1409.9,1330.9,1273.0,1220.6,1095.6,933.5,707.9,653.9cm-1;HRMS(MALDI-TOF)m/z:计算值,1984.5525[M+6H2O];测定值,1984.4323[M+6H2O]。As shown in Figure 3, then the fifth compound 5 (235.0mg, 0.15mmol), GdAc 3 (107.0mg, 0.32mmol) and NaAc (131.2mg, 1.6mmol) were dissolved in 20mL of DMF, at 70°C After stirring overnight, the resulting mixture was filtered and precipitated three times in hexane to give the corresponding desired compound TPE-2Gd in 95% yield. IR (KBr): ν = 3439.1, 1595.1, 1409.9, 1330.9, 1273.0, 1220.6, 1095.6, 933.5, 707.9, 653.9 cm -1 ; HRMS (MALDI-TOF) m/z: Calculated value, 1984.5525 [M+6H 2 O ]; measured value, 1984.4323 [M+6H 2 O].
(3)应用研究(3) Applied research
为了达到双重功能,本实施例中合成了含有GD-二乙三胺五乙酸(Gd-diethylenetriamine pentaacetic acid,DTPA)螯合物的TPE衍生物(TPE-2Gd),然后对其进行光物理性质的检测。紫外可见光谱显示TPE-2Gd的最大吸收波长在330nm,与亲代荧光素-TPE的最大吸收波长相似(未显示数据)。如图20A-20C所示,在330nm激发时,当THF/水溶液中含水量(fw)少于50%时,TPE-2Gd的荧光发光较弱。随着fw的增加,溶液的荧光逐渐变强,在纯水溶液中变成高强度发光,显示出明显的AIE效应。图20A的照片清楚地显示了,随着fw在THF/水溶液中逐渐增加,TPE-2Gd的荧光加强。In order to achieve dual functions, a TPE derivative (TPE-2Gd) containing GD-diethylenetriaminepentaacetic acid (Gd-diethylenetriamine pentaacetic acid, DTPA) chelate was synthesized in this example, and then its photophysical properties were analyzed. detection. UV-vis spectroscopy showed that TPE-2Gd had an absorption maximum at 330 nm, similar to that of the parental fluorescein-TPE (data not shown). As shown in Figures 20A-20C, when the water content (f w ) in THF/water solution is less than 50% when excited at 330 nm, the fluorescence emission of TPE-2Gd is weak. With the increase of f w , the fluorescence of the solution gradually becomes stronger, and becomes high-intensity luminescence in pure aqueous solution, showing an obvious AIE effect. The photographs in Fig. 20A clearly show that the fluorescence of TPE-2Gd increases with increasing f w in THF/water solution.
从图20C可以注意到,当染色剂浓度从1μM增加到100μM时,TPE-2Gd在纯水中的荧光强度增加了一倍。推测两亲性TPE-2Gd分子高浓度时可以形成胶束。由于AIE性质,TPE-2Gd的临界胶团浓度(CMC)可以利用荧光强度进行估测。当浓度低于CMC时,染色剂分子可以较好地溶解于溶液中,因此不发冷光。当染色剂浓度高于10μM,溶液发光。如图21A-21C所示,荧光强度与染色剂浓度之间的相关曲线形成两条,两条线的交叉点给出CMC为70μM,该值比十二烷基硫酸钠的值(CMC=8.2mM)要低得多,主要是由于TPE配基的强疏水性导致的。这样低的CMC即使是在血流稀释下也可以确保在体内形成纳米聚合物。如图22A和22B所示,通过透射电子显微镜和电动电势粒度分析仪证实了在高染色剂浓度下形成纳米聚合物。含水胶束的有效直径为164.9nm,脱水后缩减为70nm。纳米聚合物的粒径适合于体外细胞摄取和体内循环以及生物分布。It can be noticed from Fig. 20C that the fluorescence intensity of TPE-2Gd in pure water doubled when the dye concentration was increased from 1 μM to 100 μM. It is speculated that the amphiphilic TPE-2Gd molecules can form micelles at high concentrations. Due to the AIE properties, the critical micelle concentration (CMC) of TPE-2Gd can be estimated using the fluorescence intensity. When the concentration is lower than the CMC, the dye molecules can be better dissolved in the solution and therefore do not emit luminescence. When the dye concentration is higher than 10 μM, the solution emits light. As shown in Figures 21A-21C, the correlation curve between the fluorescence intensity and the concentration of the dye forms two lines, and the intersection of the two lines gives a CMC of 70 μM, which is higher than the value of sodium dodecyl sulfate (CMC=8.2 mM) is much lower, mainly due to the strong hydrophobicity of the TPE ligand. Such a low CMC ensures the formation of nanopolymers in vivo even under blood dilution. As shown in Figures 22A and 22B, the formation of nanopolymers at high dye concentrations was confirmed by transmission electron microscopy and zeta potential particle size analyzer. The effective diameter of the aqueous micelles is 164.9nm, which shrinks to 70nm after dehydration. The particle size of the nanopolymer is suitable for in vitro cellular uptake and in vivo circulation and biodistribution.
由FDA批准的一种商用的Gd-基MR(Gd-based MR)造影剂是一种典型的细胞外液试剂,在细胞外区或组织间隙可快速循环。另一方面,TPE-2Gd能够以纳米聚合物的形式进入肿瘤细胞内,已通过活细胞成像进行证明。HeLa细胞由30μM的TPE-2Gd培养4小时,TPE-2Gd进入至该细胞内,通过蓝色荧光照亮细胞质区。为了进一步证实TPE-2Gd的染色区,使用PI作为复染色剂。PI是可染色固定细胞的细胞核的细胞核染色剂。如图23A-23D所示,在细胞核周围的蓝色荧光清楚地表明TPE-2Gd选择性仅对细胞质区染色。TPE-2Gd的纳米聚合物通过内吞作用的途径被内在化进入活细胞,使得TPE-2Gd可以在细胞水平上追踪肿瘤,弥补了在组织水平上追踪肿瘤的缺陷。A commercial Gd-based MR (Gd-based MR) contrast agent approved by the FDA It is a typical extracellular fluid reagent, which can circulate rapidly in the extracellular area or interstitial space. On the other hand, TPE-2Gd can enter tumor cells in the form of nanopolymers, which has been demonstrated by live cell imaging. HeLa cells were cultured with 30 μM TPE-2Gd for 4 hours, and TPE-2Gd entered the cells and illuminated the cytoplasmic region through blue fluorescence. To further confirm the staining area of TPE-2Gd, PI was used as a counterstain. PI is a nuclear stain that stains the nucleus of fixed cells. As shown in Figures 23A-23D, the blue fluorescence around the nucleus clearly indicates that TPE-2Gd selectively stains only the cytoplasmic region. The nanopolymers of TPE-2Gd are internalized into living cells through the pathway of endocytosis, so that TPE-2Gd can track tumors at the cellular level, making up for the Tracking tumor defects at the tissue level.
利用MTT法测定了TPE-2Gd在HeLa细胞内的毒性。将细胞暴露于不同浓度的TPE-2Gd(0、15μM、30μM、45μM和60μM)4小时,然后在新鲜的培养基内培养24小时,用于评估纳米聚合物对细胞增殖的内在化影响。如图24所示,当TPE-2Gd的浓度低于30μM时,通常是没有毒性的,在用染色剂处理后,约98.8%的细胞都是活的。即使浓度增加至60μM,比细胞成像实验的工作浓度高出2倍,细胞存活率仍然约有87.8%。这个结果表明TPE-2Gd是生物可相容的用于细胞成像,并有望进一步进行体内研究。The toxicity of TPE-2Gd in HeLa cells was determined by MTT assay. Cells were exposed to different concentrations of TPE-2Gd (0, 15 μM, 30 μM, 45 μM, and 60 μM) for 4 h, and then cultured in fresh medium for 24 h to evaluate the internalization effect of nanopolymers on cell proliferation. As shown in Figure 24, when the concentration of TPE-2Gd was lower than 30 μM, it was generally not toxic, and about 98.8% of the cells were viable after treatment with the stain. Even when the concentration was increased to 60 μM, which is 2 times higher than the working concentration of the cell imaging experiment, the cell viability was still about 87.8%. This result indicates that TPE-2Gd is biocompatible for cell imaging and holds promise for further in vivo studies.
在另一方面,为了检测TPE-2Gd是否为有效的MRI造影剂,使用3.0T核磁共振成像(MRI)仪器在室温下根据Gd3+浓度测定水溶液中TPE-2Gd的纵向弛豫时间或自旋晶格(T1)。如图25所示,随着缓冲溶液中TPE-2Gd浓度的增加,混合物的信号强度(亮度)变强,与相同Gd3+浓度的相似。如图26所示,测定TPE-2Gd的弛豫效能是3.36±0.10mM-1·s-1,的弛豫效能是3.70±0.02mM-1·s-1,弛豫效能是指每单位浓度的造影剂中自旋晶格的顺磁性成分。与相比,TPE-2Gd具有高弛豫速率,表明TPE-2Gd可以加强其邻近的水质子的弛豫速率,进而导致信号强度增强。如图27、图28A、图28B和图29所示,TPE-2GD作为纳米粒子,在血液中的半衰期较长,可以用于延长肝脏和心脏MRI成像的时间窗。On the other hand, in order to detect whether TPE-2Gd is an effective MRI contrast agent, the longitudinal relaxation time or spin of TPE- 2Gd in aqueous solution was determined according to the Gd concentration at room temperature using a 3.0T nuclear magnetic resonance imaging (MRI) instrument. Lattice (T 1 ). As shown in Figure 25, as the concentration of TPE-2Gd in the buffer solution increases, the signal intensity (brightness) of the mixture becomes stronger, which is comparable to that of the same Gd 3+ concentration resemblance. As shown in Figure 26, the measured relaxation performance of TPE-2Gd is 3.36±0.10mM -1 ·s -1 , The relaxation efficiency of is 3.70±0.02mM -1 ·s -1 , and the relaxation efficiency refers to the paramagnetic component of the spin lattice in the contrast agent per unit concentration. and In contrast, TPE-2Gd has a high relaxation rate, indicating that TPE-2Gd can enhance the relaxation rate of its neighboring water protons, which in turn leads to enhanced signal intensity. As shown in Figure 27, Figure 28A, Figure 28B and Figure 29, as nanoparticles, TPE-2GD has a longer half-life in blood, and can be used to extend the time window of liver and cardiac MRI imaging.
应当理解的是,对本领域普通技术人员来说,可以根据上述说明加以改进或变换,所有这些改进或变换都应属于本发明所附权利要求的保护范围之内。It should be understood that those skilled in the art may make improvements or changes based on the above description, and all such improvements or changes shall fall within the protection scope of the appended claims of the present invention.
Claims (13)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610671437.7A CN106631997B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
| CN201610672077.2A CN106566532B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461995281P | 2014-04-07 | 2014-04-07 | |
| US61/995,281 | 2014-04-07 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610671437.7A Division CN106631997B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
| CN201610672077.2A Division CN106566532B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104974745A true CN104974745A (en) | 2015-10-14 |
| CN104974745B CN104974745B (en) | 2017-01-18 |
Family
ID=54271721
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610671437.7A Active CN106631997B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
| CN201610672077.2A Active CN106566532B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
| CN201510159050.9A Active CN104974745B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic luminescent substance with aggregation-induced luminescent properties and its application |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610671437.7A Active CN106631997B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
| CN201610672077.2A Active CN106566532B (en) | 2014-04-07 | 2015-04-03 | Amphiphilic shiner and its application with aggregation-induced emission characteristic |
Country Status (1)
| Country | Link |
|---|---|
| CN (3) | CN106631997B (en) |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105833791A (en) * | 2016-03-30 | 2016-08-10 | 大连理工大学 | A kind of surfactant containing o-nitrobenzyl ester photodegradation group and preparation method thereof |
| CN106000216A (en) * | 2016-05-16 | 2016-10-12 | 北京化工大学 | Surfactant with aggregation-induced emission effect |
| WO2016206615A1 (en) * | 2015-06-24 | 2016-12-29 | The Hong Kong University Of Science And Technology | Aie luminogens for visualization and treatment of cancer |
| CN106814052A (en) * | 2017-01-06 | 2017-06-09 | 中国工程物理研究院核物理与化学研究所 | A kind of recognition methods of scandium ion |
| US20170172991A1 (en) * | 2015-12-17 | 2017-06-22 | University Of Iowa Research Foundation | Image guided therapy for cancer |
| WO2017128921A1 (en) * | 2016-01-28 | 2017-08-03 | 华南理工大学 | High-polymer vesicle containing aggregation-induced emission molecules as well as preparation method therefor and application thereof |
| CN107011244A (en) * | 2017-04-20 | 2017-08-04 | 北京理工大学 | Benzocyclobutane diene with AEE effects and azole derivatives and its preparation |
| WO2018014865A1 (en) * | 2016-07-21 | 2018-01-25 | The Hong Kong University Of Science And Technology | Aiegens for cancer cell imaging |
| WO2018068688A1 (en) * | 2016-10-13 | 2018-04-19 | The Hong Kong University Of Science And Technology | Polymer poly (triphenylacrylonitrite) and synthesis thereof |
| WO2018103262A1 (en) * | 2016-12-08 | 2018-06-14 | 南方科技大学 | Extracellular ratio-type oxygen sensing probe and preparation method and use thereof |
| CN108593608A (en) * | 2018-02-08 | 2018-09-28 | 陕西师范大学 | Tetraphenyl ethylene pyridiniujm is in detection NO3-And ClO4-In application |
| CN110234735A (en) * | 2017-04-20 | 2019-09-13 | 香港科技大学 | Probe is used in bi-mode biology imaging |
| US10729669B2 (en) | 2015-07-28 | 2020-08-04 | University Of Iowa Research Foundation | Compositions and methods for treating cancer |
| CN111595829A (en) * | 2019-12-12 | 2020-08-28 | 北京化工大学 | A method for selective imaging of capsular bacteria with tetraphenylene derivatives |
| CN111825634A (en) * | 2020-08-02 | 2020-10-27 | 华中科技大学同济医学院附属协和医院 | Novel compound, its preparation method and its application |
| US11179484B2 (en) | 2016-06-24 | 2021-11-23 | University Of Iowa Research Foundation | Compositions and methods of treating melanoma |
| CN114907222A (en) * | 2022-06-23 | 2022-08-16 | 扬州大学 | A TPE-based aggregation-induced luminescence fluorescent probe and use thereof |
| CN115010725A (en) * | 2022-06-06 | 2022-09-06 | 华南师范大学 | Amphiphilic small molecule prodrug and preparation method and application thereof |
| CN115466210A (en) * | 2022-09-21 | 2022-12-13 | 哈尔滨工业大学(深圳) | A fluorescent probe for detecting outer membrane vesicles and its application |
| US11529335B2 (en) | 2020-07-31 | 2022-12-20 | University Of Iowa Research Foundation | Compositions and methods for treating cancer |
| WO2023142326A1 (en) * | 2022-01-30 | 2023-08-03 | 月亮小屋(中国)有限公司 | Aie fluorescent probe composition, cmc measurement method and device for surfactant solution, and cmc determination method and device |
| CN116925086A (en) * | 2023-09-19 | 2023-10-24 | 南昌大学 | Triazole macrocyclic compounds, synthesis methods and their application in nitrite detection |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111263751B (en) * | 2017-10-24 | 2022-12-27 | 香港科技大学 | Water-soluble compounds having aggregation-induced emission properties |
| WO2019088266A1 (en) * | 2017-11-06 | 2019-05-09 | コニカミノルタ株式会社 | Aggregated nanoparticles and fluorescent labeling material |
| CN111019642B (en) * | 2018-10-09 | 2021-09-14 | 北京大学 | Preparation method of dual-wavelength detection and full-spectrum adjustment composite fluorescent micelle and application of composite fluorescent micelle in aqueous anti-counterfeiting ink |
| CN110448700B (en) * | 2019-08-26 | 2020-12-25 | 中山大学附属第六医院 | Nano drug-loaded compound for targeted diagnosis and treatment of gastric cancer and preparation method thereof |
| CN112441965A (en) * | 2020-12-18 | 2021-03-05 | 西北师范大学 | Preparation method of nano assembly with AIE effect |
| CN114835638B (en) * | 2022-03-04 | 2023-05-23 | 中国地质大学(武汉) | AIE molecule with double-end-group modified site, multi-module probe, preparation method and application thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013029340A1 (en) * | 2011-09-01 | 2013-03-07 | The Hong Kong University Of Science And Technology | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging |
| CN103196874A (en) * | 2012-01-09 | 2013-07-10 | 纳米及先进材料研发院有限公司 | Urinary protein detection device based on aggregation-induced luminescence (AIE) for monitoring human health |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103630529B (en) * | 2012-08-24 | 2018-01-26 | 国家纳米科学中心 | A method for detecting casein in dairy products using tetraphenylethylene derivatives |
| CN103529017B (en) * | 2013-10-09 | 2017-02-08 | 国家纳米科学中心 | Enzyme-responsive self-aggregation luminous molecule and applications thereof in monitoring enzyme activity |
-
2015
- 2015-04-03 CN CN201610671437.7A patent/CN106631997B/en active Active
- 2015-04-03 CN CN201610672077.2A patent/CN106566532B/en active Active
- 2015-04-03 CN CN201510159050.9A patent/CN104974745B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013029340A1 (en) * | 2011-09-01 | 2013-03-07 | The Hong Kong University Of Science And Technology | Biocompatible nanoparticles with aggregation induced emission characteristics as fluorescent bioprobes and methods of using the same for in vitro and in vivo imaging |
| CN103196874A (en) * | 2012-01-09 | 2013-07-10 | 纳米及先进材料研发院有限公司 | Urinary protein detection device based on aggregation-induced luminescence (AIE) for monitoring human health |
Non-Patent Citations (3)
| Title |
|---|
| JIAN WANG,ET AL.: "Ethynyl-Capped Hyperbranched Conjugated Polytriazole: Click Polymerization, Clickable Modification, and Aggregation-Enhanced Emission", 《MACROMOLECULES》 * |
| QIN ANJUN,ET AL.: "Preparation and self-assembly of amphiphilic polymer with aggregation-induced emission characteristics", 《SCIENCE CHINA CHEMISTRY》 * |
| 金佳科,等: "用水溶性四苯基乙烯基荧光探针检测ctDNA", 《高分子学报》 * |
Cited By (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10935552B2 (en) | 2015-06-24 | 2021-03-02 | The Hong Kong University Of Science And Technology | Aie luminogens for visualization and treatment of cancer |
| WO2016206615A1 (en) * | 2015-06-24 | 2016-12-29 | The Hong Kong University Of Science And Technology | Aie luminogens for visualization and treatment of cancer |
| CN111909114A (en) * | 2015-06-24 | 2020-11-10 | 香港科技大学 | AIE luminophores for cancer visualization and treatment |
| US11596613B2 (en) | 2015-07-28 | 2023-03-07 | University Of Iowa Research Foundation | Compositions and methods for treating cancer |
| US10729669B2 (en) | 2015-07-28 | 2020-08-04 | University Of Iowa Research Foundation | Compositions and methods for treating cancer |
| US9980951B2 (en) * | 2015-12-17 | 2018-05-29 | University Of Iowa Research Foundation | Image guided therapy for cancer |
| US20170172991A1 (en) * | 2015-12-17 | 2017-06-22 | University Of Iowa Research Foundation | Image guided therapy for cancer |
| WO2017128921A1 (en) * | 2016-01-28 | 2017-08-03 | 华南理工大学 | High-polymer vesicle containing aggregation-induced emission molecules as well as preparation method therefor and application thereof |
| CN105833791A (en) * | 2016-03-30 | 2016-08-10 | 大连理工大学 | A kind of surfactant containing o-nitrobenzyl ester photodegradation group and preparation method thereof |
| CN106000216A (en) * | 2016-05-16 | 2016-10-12 | 北京化工大学 | Surfactant with aggregation-induced emission effect |
| CN106000216B (en) * | 2016-05-16 | 2017-10-31 | 北京化工大学 | Surfactant with aggregation-induced emission effect |
| US11179484B2 (en) | 2016-06-24 | 2021-11-23 | University Of Iowa Research Foundation | Compositions and methods of treating melanoma |
| US11576987B2 (en) | 2016-06-24 | 2023-02-14 | University Of Iowa Research Foundation | Compositions and methods of treating melanoma |
| US11578265B2 (en) | 2016-07-21 | 2023-02-14 | The Hong Kong University Of Science And Technology | AIEgens for cancer cell imaging |
| CN109313135A (en) * | 2016-07-21 | 2019-02-05 | 香港科技大学 | Aggregation-inducing luminophores for cancer cell imaging |
| WO2018014865A1 (en) * | 2016-07-21 | 2018-01-25 | The Hong Kong University Of Science And Technology | Aiegens for cancer cell imaging |
| CN109843970A (en) * | 2016-10-13 | 2019-06-04 | 香港科技大学 | Poly- (triphenyl acrylonitrile) polymer and its synthesis |
| CN109843970B (en) * | 2016-10-13 | 2021-05-25 | 香港科技大学 | Poly(triphenylacrylonitrile) polymer and its synthesis |
| US10941243B2 (en) | 2016-10-13 | 2021-03-09 | The Hong Kong University Of Science And Technology | Polymer poly (triphenylacrylonitrite) and synthesis thereof |
| WO2018068688A1 (en) * | 2016-10-13 | 2018-04-19 | The Hong Kong University Of Science And Technology | Polymer poly (triphenylacrylonitrite) and synthesis thereof |
| WO2018103262A1 (en) * | 2016-12-08 | 2018-06-14 | 南方科技大学 | Extracellular ratio-type oxygen sensing probe and preparation method and use thereof |
| CN106814052A (en) * | 2017-01-06 | 2017-06-09 | 中国工程物理研究院核物理与化学研究所 | A kind of recognition methods of scandium ion |
| CN107011244A (en) * | 2017-04-20 | 2017-08-04 | 北京理工大学 | Benzocyclobutane diene with AEE effects and azole derivatives and its preparation |
| CN110234735A (en) * | 2017-04-20 | 2019-09-13 | 香港科技大学 | Probe is used in bi-mode biology imaging |
| CN107011244B (en) * | 2017-04-20 | 2019-06-28 | 北京理工大学 | Benzocyclobutane diene with AEE effect and azole derivatives and its preparation |
| CN108593608A (en) * | 2018-02-08 | 2018-09-28 | 陕西师范大学 | Tetraphenyl ethylene pyridiniujm is in detection NO3-And ClO4-In application |
| CN111595829A (en) * | 2019-12-12 | 2020-08-28 | 北京化工大学 | A method for selective imaging of capsular bacteria with tetraphenylene derivatives |
| CN111595829B (en) * | 2019-12-12 | 2021-10-01 | 北京化工大学 | A method for selective imaging of capsular bacteria with tetraphenylene derivatives |
| US11529335B2 (en) | 2020-07-31 | 2022-12-20 | University Of Iowa Research Foundation | Compositions and methods for treating cancer |
| CN111825634A (en) * | 2020-08-02 | 2020-10-27 | 华中科技大学同济医学院附属协和医院 | Novel compound, its preparation method and its application |
| WO2023142326A1 (en) * | 2022-01-30 | 2023-08-03 | 月亮小屋(中国)有限公司 | Aie fluorescent probe composition, cmc measurement method and device for surfactant solution, and cmc determination method and device |
| CN115010725A (en) * | 2022-06-06 | 2022-09-06 | 华南师范大学 | Amphiphilic small molecule prodrug and preparation method and application thereof |
| CN115010725B (en) * | 2022-06-06 | 2023-06-02 | 华南师范大学 | A kind of amphiphilic small molecule prodrug and its preparation method and application |
| CN114907222A (en) * | 2022-06-23 | 2022-08-16 | 扬州大学 | A TPE-based aggregation-induced luminescence fluorescent probe and use thereof |
| CN114907222B (en) * | 2022-06-23 | 2024-03-26 | 扬州大学 | A kind of TPE-based aggregation-induced luminescence fluorescent probe and its use |
| CN115466210A (en) * | 2022-09-21 | 2022-12-13 | 哈尔滨工业大学(深圳) | A fluorescent probe for detecting outer membrane vesicles and its application |
| CN116925086A (en) * | 2023-09-19 | 2023-10-24 | 南昌大学 | Triazole macrocyclic compounds, synthesis methods and their application in nitrite detection |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106631997B (en) | 2019-10-29 |
| CN106631997A (en) | 2017-05-10 |
| CN104974745B (en) | 2017-01-18 |
| CN106566532B (en) | 2019-03-22 |
| CN106566532A (en) | 2017-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104974745B (en) | Amphiphilic luminescent substance with aggregation-induced luminescent properties and its application | |
| Liu et al. | A cyanine-modified nanosystem for in vivo upconversion luminescence bioimaging of methylmercury | |
| Jiang et al. | Facile construction and biological imaging of cross-linked fluorescent organic nanoparticles with aggregation-induced emission feature through a catalyst-free azide-alkyne click reaction | |
| Wang et al. | Advances in luminescent materials with aggregation-induced emission (AIE) properties for biomedical applications | |
| Hada et al. | Folic acid functionalized gold nanoclusters for enabling targeted fluorescence imaging of human ovarian cancer cells | |
| S. Marfin et al. | Recent advances of individual BODIPY and BODIPY-based functional materials in medical diagnostics and treatment | |
| Stasiuk et al. | Cell-permeable Ln (III) chelate-functionalized InP quantum dots as multimodal imaging agents | |
| CN104334162B (en) | A multicolor pH-activatable fluorescent nanoplatform | |
| Xu et al. | Deep-red fluorescent organic nanoparticles with high brightness and photostability for super-resolution in vitro and in vivo imaging using STED nanoscopy | |
| Cserép et al. | Bioorthogonal fluorescent labels: a review on combined forces | |
| Xu et al. | Radical induced quartet photosensitizers with high 1O2 production for in vivo cancer photodynamic therapy | |
| Hou et al. | Recent advances of pure organic room temperature phosphorescence materials for bioimaging applications | |
| Li et al. | Europium-complex-grafted polymer dots for amplified quenching and cellular imaging applications | |
| Lu et al. | Cyclometalated iridium (iii) complex nanoparticles for mitochondria-targeted photodynamic therapy | |
| Sarkar et al. | Naphthalimide based fluorescent organic nanoparticles in selective sensing of Fe 3+ and as a diagnostic probe for Fe 2+/Fe 3+ transition | |
| EP3679608B1 (en) | Triplet-triplet annihilation upconversion system, and compositions and methods thereof for drug delivery | |
| Fang et al. | Europium-doped nanoparticles for cellular luminescence lifetime imaging via multiple manipulations of aggregation state | |
| Zhang et al. | Photo-controlled reversible secondary self-assembly of supramolecular nanosheets and their drug delivery behavior | |
| Xu et al. | One-step synthesis of europium complexes containing polyamino acids through ring-opening polymerization and their potential for biological imaging applications | |
| CN115006527B (en) | A kind of mitochondria targeting photosensitizer and its preparation method and application | |
| Gkika et al. | Os (II)-bridged polyarginine conjugates: the additive effects of peptides in promoting or preventing permeation in cells and multicellular tumor spheroids | |
| US20120070378A1 (en) | Lanthanide ion complexes and imaging method | |
| US10927221B2 (en) | Dendrimeric metallacrowns | |
| Ma et al. | Water-soluble iridium (III) complexes as multicolor probes for one-photon, two-photon and fluorescence lifetime imaging | |
| Deng et al. | A dual donor–acceptor fluorescent probe with viscosity response and lipid droplets targeting to initiate oxidative stress for tumor elimination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |